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A B S T R A C TThe	  speci^ic	  recognition	  by	  proteins	  of	  the	  5´	  and	  3´	  ends	  of	  RNA	  molecules	  is	  an	  impor-­‐tant	   facet	  of	  many	  cellular	  processes,	  including	  RNA	  maturation,	   regulation	  of	   transla-­‐tion	  initiation	  and	  control	  of	  gene	  expression	  by 	  degradation	  and	  RNA	  interference.	  The	  aim	   of	   this	   review	   is	   to	   survey	   recent	   structural	   analyses	  of	  protein	  binding	   domains	  that	   speci^ically	  bind	   to	  the	  extreme	  5´	  or	  3´	  termini	  of	  RNA.	  For	  reasons	  of	  space	   and	  because	   their	   interactions	  are	   also	   governed	   by	  catalytic	   considerations,	  we	   have	   ex-­‐cluded	  enzymes	  that	  modify	  the	   5´	  and	   3´	   extremities	  of	  RNA.	  It	   is	   clear	   that	   there	   is	  enormous	  structural	  diversity	  among	   the	  proteins	  that	  have	  evolved	  to	  bind	  to	  the	  ends	  of	  RNA	  molecules.	  Moreover,	  they	  commonly	  exhibit	  conformational	   ^lexibility	  that	  ap-­‐pears	  to	  be	  important	  for	  binding	   and	  regulation	  of	  the	   interaction.	  This	  ^lexibility	  has	  sometimes	  complicated	  the	  interpretation	  of	  structural	   results	  and	  presents	  signi^icant	  challenges	  for	  future	  investigations.
1.	  	  IntroductionSpeci^ic	  binding	   of	  proteins	   to	   the	   5´	   and	   3´	   ends	  of	  RNA	  is	  crucial	  for	  many	  aspects	  of	  the	  production	  and	  use	  of	  RNA	  mole-­‐cules	  in	  living	   cells.	  Within	  the	  past	  several	  years,	  structural	  stud-­‐ies	   have	   greatly	   increased	   our	  understanding	   of	   the	   molecular	  details	   of	   these	   protein-­‐RNA	   recognition	   events.	   They	   involve	   a	  wide	   variety	   of	   RNA	   molecules,	   in	   single	   and	   double-­‐stranded	  RNA	  contexts,	  and	  play	  important	  roles	  in	  many	  different	  cellular	  functions,	   including	   RNA	  maturation,	   translational	   control,	   regu-­‐lation	   of	   gene	   expression	   and	   viral	   defense	   mechanisms	   (and	  counter-­‐measures).	  This	  topic	  has	  already	  been	  touched	  upon	   in	   several	  excellent	  reviews,	   usually	  devoted	   to	  a	   speci^ic	   functional	   context,	  for	  ex-­‐ample,	  5´	  cap	  binding	   [1,	  2],	  RNA	  interference	   [3-­‐5]	  or	  ribonucle-­‐ase	   function	  [6].	  Although	  in	  many	  cases,	  the	  5´	  and	  3´	  termini	  of	  RNA	  undergo	  modi^ication	  in	   the	   cell,	  requiring	   speci^ic	   recogni-­‐tion	   of	  the	   ends	  to	   be	   processed	   by	  the	  modifying	  enzymes	  (e.g.	  polymerases,	  CCA-­‐adding	   enzymes,	  aminoacyl	   tRNA	  synthetases,	  pyrophosphohydrolases,	   5´-­‐capping	   and	   decapping	   enzymes),	  these	   will	   not	   be	   reviewed	   here.	   In	   part	   this	   is	   for	   reasons	   of	  space	  but	  it	  also	  re^lects	  the	  fact	  that	  recognition	  events	  involved	  in	  enzymatic	  processing	  are	  more	  dynamic—often	  coupled	  to	  the	  binding	   of	   other	   substrates	   of	   the	   modi^ication	   reaction—and	  arguably	   re^lect	   a	   distinct	   class	   of	  binding	   interaction.	   Here	   we	  will	   review	   structural	   analyses	   of	   binding	   domains	   that	   have	  evolved	  to	  speci^ically 	  recognise	  the	  extreme	  5´ 	  or	  3´	  ends	  of	  RNA,	  
either	   separately	  or	  together,	   with	  a	   particular	   focus	   on	  more	   re-­‐cent	  results.	  
2.	  	  5´	  cap	  recognition
2.1.	  	  The	  architecture	  of	  cap-­binding	  proteins.	  The	   5´	  cap	  structure	  (m7GpppN)	   is	   formed	  by	  the	  enzymatic	  ad-­‐dition	   of	   N7-­‐methylated	   guanosine	   (G)	   to	   the	   ^irst	   base	   (N)	   of	  eukaryotic	   RNA	   polymerase	   II	   transcripts	   such	   as	   mRNA	   and	  U	   snRNA.	   Capping	   is	   essential	   for	   mRNA	   transport,	   processing,	  translation	  and	  protection	  from	  degradation	  by	  5´	  exonucleases	  [1,	  2].	  These	   functions	  are	  mediated	  by	  several	   proteins	  that	  interact	  speci^ically	   with	   the	   5´	   cap	   structure.	   The	   molecular	   details	   of	  these	   binding	   interactions	   have	   been	   obtained	   from	   extensive	  structural	  and	   functional	  studies	  of	  cellular	  and	  viral	   proteins.	  In-­‐terestingly,	  these	  proteins	  have	  disparate	  origins	  and	  very 	  different	  structures	   (Fig.	   1);	   however,	   they	   share	   a	   similar	   aromatic	   cap-­‐binding	   pocket,	   and	   represent	   an	   interesting	   case	   of	   convergent	  evolution	  [2].	  One	  of	  the	  best	  studied	  5´	  cap-­‐binding	  proteins	  is	  the	  eukaryotic	  initiation	   factor	  4E	   (eIF4E),	  which	  is	  essential	   for	  the	  initiation	  of	  translation	   of	  capped	  mRNAs	   [7].	  It	  associates	  with	   eIF4G,	  which	  facilitates	   cap	   binding,	  and	   eIF4A	  to	  form	   the	   eIF4F	  complex	   that	  helps	  to	  recruit	  the	  40S	   ribosomal	  subunit	  to	  the	  mRNA	  to	  initiate	  translation	  [8].	  In	  mammals	   the	  eIF4E	  family	  contains	  three	  mem-­‐bers:	  eIF4E	  (eIF4E-­‐1),	  4EHP	  (eIF4E-­‐2)	  and	  eIF4E-­‐3	  [9].	  Human	  4E	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homology	   protein	   (h4EHP)	   is	   30%	   identical	   in	   amino	   acid	   se-­‐quence	   to	  eIF4E	   and	  binds	   both	   the	   m7G	  cap	  on	  mRNA	  and	   the	  regulator	  protein,	  4E	   binding	   protein	  1	  (4E-­‐BP1),	  but	  —	  intrigu-­‐ingly	  —	   does	  not	   interact	   with	   eIF4G	  and	   its	   physiological	   role	  remains	  unclear	  [9-­‐11].	  The	  structures	  of	  eIF4E	  and	  h4EHP	  in	  the	  apo	   and	  m7GTP-­‐bound	  forms	   are	   very	   similar,	  possessing	   a	   cen-­‐tral	   curved	   β-­‐sheet	   ^lanked	   by	   three	   helices	  on	  a	   convex	   ‘outer’	  surface	  and	  an	  m7GTP	  binding	  pocket	  on	  the	   ‘inner’	  concave	  side	  [12-­‐15]	  (Fig.	  1c).	  Most	  of	  the	  residues	  involved	  in	  cap	  binding	  are	  conserved	  between	  the	  two	  proteins	  [10,	  14].	  Prior	  to	  reaching	   eIF4E	   in	  the	  cytoplasm,	   the	  mRNA	  in	   the	   nu-­‐cleus	  is	  partnered	  by	  the	  nuclear	  Cap	  Binding	  Complex,	  CBC.	  This	  heterodimeric	   complex	   consists	   of	   the	   5´	   cap	   binding	   protein,	  CBP20,	   in	   association	   with	   the	   larger	   ancillary	   protein,	   CBP80.	  CBP20	   contains	   an	  RNA	  Recognition	  Motif	   (RRM)	   that	  binds	   to	  the	   m7GpppG	   cap	   structure	   using	   the	   central	   ‑sheet	   platform	  while	   engaging	   CBP80	   via	   its	   dorsal	   helical	   surface	   and	   an	   N-­‐terminal	   extension	  [16-­‐18]	   (Fig.	  1a),	  an	  interaction	   that	   is	  neces-­‐sary	   for	   cap-­‐binding	   [19].	   Exemplifying	   the	   highly	   adaptable	  properties	  of	  the	  RRM	  platform,	  CBP20	  binds	  capped	  RNA	  across	  its	  β-­‐sheet	  RNA-­‐binding	   surface	   in	   the	   opposite	  direction	  to	  that	  observed	   for	   RNA	   ligands	   of	   all	   other	   RRM	   domains	   that	   have	  been	  examined	  structurally	  [17,	  20].	  CBP80	  has	  also	  been	   shown	  to	   associate	   with	   another	   cap-­‐interacting	   protein,	   the	   poly-­‐A-­‐speci^ic	  ribonuclease	  (PARN)	  [21].	  PARN,	  a	  speci^ic	  3´	  exoribonu-­‐clease	   involved	  in	  mRNA	  decay,	  is	  unique	  among	   the	  poly(A)	   nu-­‐cleases	   since	   it	   interacts	  with	  both	   the	  3´	  en[22]d	  and	  the	  5´	  cap	  of	   the	   mRNA	   during	   deadenylation	   [23-­‐25].	   PARN	   contains	   an	  RRM	   domain	   that	   speci^ically 	  recognises	   the	   5´ 	  cap	   and	   recent	  structural	   investigations	   have	   revealed	   signi^icant	   differences	  with	  other	  cap	  binding	  proteins	  [26-­‐28]	  (see	  below).	  In	  particular,	  the	   PARN	   RRM	   differs	   strikingly	   from	   the	   CBP20	   RRM	   since	   it	  binds	   the	  cap	  not	  on	  the	  canonical	  β-­‐sheet	   surface,	  but	  at	   the	  ex-­‐treme	  edge	  of	  the	  sheet,	  in	  a	  cavity	  between	  β2	  and	  β1	  (see	  Fig.	  6	  in	  [27]).The	   cap-­‐binding	   complex	   is	   also	   involved	   in	   the	   export	   of	   the	  m7G-­‐capped	  transcripts	  of	  U1,	  U2,	  U4	  and	  U5	  snRNAs.	   In	   the	   cy-­‐toplasm,	  the	  m7G	  cap	  of	  these	  U	  snRNAs	  are	  hypermethylated	  to	  a	  2,2,7-­‐trimethyl-­‐guanosine	   cap	   form	   (m3G).	   This	   modi^ication	   al-­‐lows	   the	   speci^ic	   binding	   of	   the	   protein,	   snurportin1,	   which	   is	  necessary	  for	   re-­‐import	   of	   the	   U	   snRNPs	   to	   the	   nucleus	  where	  they	  are	  assembled	   into	   the	  spliceosome	   [22].	  Curiously	  the	   cap-­‐binding	   domain	   of	   snurportin1	   resembles	   the	   mRNA	   guanylyl-­‐transferase	   enzyme	   that	  uses	   GTP	   to	   add	   the	   guanosine	  base	   to	  mRNA	  at	  the	  outset	  of	  cap-­‐formation	  [29]	  (Fig.	  1d).	  In	  addition	  to	  cellular	  factors,	  speci^ic	  5´ 	  cap	  recognition	  is	  also	  achieved	   by	   viral	   proteins.	   In	   vaccinia	   virus,	   a	   double-­‐stranded	  DNA	   poxvirus,	   the	   cap-­‐dependent	   2´-­‐O-­‐methyltransferase	   VP39	  recognises	  its	  own	  capped	  mRNA	  [30].	  In	  the	   later	  stages	  of	  viral	  mRNA	  cap	  synthesis,	  VP39	  transfers	  a	  methyl	  group	  to	  the	  ribose	  2´-­‐OH	  of	  the	  ^irst	  transcribed	  residue	  of	  the	  capped	  mRNA	  to	  pro-­‐duce	  a	   ‘cap	  I’	   type	  structure	  (m7Gppp(Gm/Am)).	  VP39	  has	  a	   com-­‐pact	   globular	   α/β	   domain	   similar	   to	   the	   catalytic	   domains	   of	  other	  methyltransferases	   (see	  Fig.	  1	   in	   [31]).	  The	  core	   of	  the	  do-­‐main	   speci^ically 	  binds	  the	  m7G	  cap	  of	  the	  mRNA	   to	  one	   side	  of	  the	   active	   site,	   thereby	  placing	   the	   ^irst	   transcribed	   base	   in	   the	  enzyme	  active	  site	  [32,	  33].
In	  contrast	   to	  vaccinia	  virus,	  in^luenza	   virus	  does	  not	  synthesise	  its	   own	   caps	   but	   steals	   them	   from	   cellular	   mRNA	   in	   a	   process	  known	   as	   cap-­‐snatching	   that	   is	   performed	   by	   the	   heterotrimeric	  viral	  polymerase,	  formed	  from	  PA,	  PB1	  and	  PB2	  subunits.	   	  Immedi-­‐ately	  prior	  to	  transcription	  of	  viral	  mRNA,	  the	  5´ 	  cap	  of	  host	  mRNA	  is	  bound	  by	  PB2	  [34],	  and	  then	  cleaved	  at	  nucleotide	  10-­‐13	  by	  the	  endonuclease	   subunit,	  PA	  [35,	  36].	  The	  minimal	   cap-­‐binding	   frag-­‐ment	   of	   PB2	   has	  a	   compact	   α/β	   architecture	   which	   does	   not	   re-­‐semble	   any	  known	  fold	   [34]	   (Fig.	  1b).	  The	  m7G	  moiety	  binds	  in	  a	  pocket	  on	  PB2	  at	  the	   interface	  of	  the	  concave	  side	  of	  the	  ‑sheet	  and	  the	  ^lanking	  ‑helices	  [34].
2.2.	  	  Structural	  features	  of	  protein	  5´	  cap	  recognition.Despite	   the	   architectural	   differences	   between	   the	   5´	   cap-­‐binding	   proteins,	   the	   speci^ic	  mode	   of	   recognition	   of	   the	   cap	   fol-­‐lows	  a	  common	   theme,	   invariably	  involving	   base-­‐stacking	   interac-­‐tions	  with	  aromatic	  side	  chains	  [1,	  2,	  14,	  34].	  In	  most	  cases	  the	  m7G	  base	   is	   stacked	   between	   	  two	  aromatic	  amino	  acids	  in	   a	   ‘cation-­‐-­‐sandwich’,	   where	   the	   delocalised	  positive	   charge	   of	   the	   base	   that	  arises	   from	   methylation	   of	   N7	   of	   the	   base	   forms	   strong	   electro-­‐static	  interactions	  with	  the	   	  aromatic	  electrons	   (Fig.	  1e).	  The	  pair	  of	  aromatic	   residues	   involved	   in	   this	   sandwich	   stacking	   arrange-­‐ment	   have	   been	   identi^ied	   as	   Trp	   102/Trp	   56	   in	   eIF4E,	  Tyr	   20/Tyr	   43	   in	   CBP20,	   Tyr	   22/Phe	   180	   in	   VP39,	   Tyr	   78/Trp	   124	   in	  h4EHP	   and	   Phe	   404/His	   357	   in	   PB2.	   With	   one	   exception,	   the	  plane-­‐parallel	   stacking	   of	   the	   methylated	   base	   between	   the	   two	  aromatic	   rings	   is	   very	   similar,	   suggesting	   that	   this	   sandwich	   ar-­‐rangement	  exerts	  a	   powerful	  grip	  on	   the	  methylated	  base.	  Substi-­‐tution	   of	   the	   aromatic	   groups	   with	   aliphatic	   residues	   decreases	  speci^icity	  and	  af^inity	  for	  the	   cap	  structure,	  underscoring	   the	   im-­‐portance	   of	  the	   aromatic	   stacking	   interaction	   for	  speci^ic	   cap	  rec-­‐ognition	   [17,	   33,	   34,	   37].	   Curiously,	   the	   two-­‐sided	   sandwich	   ar-­‐rangement	   is	   rarely	  observed	   in	   proteins	  that	   speci^ically	  bind	  to	  unmodi^ied	  RNA	  bases;	  the	  best	  known	  examples	  are	   the	  PUF	  pro-­‐teins,	  though	  even	  here	  Tyr/Arg	   sandwich	  pairs	  are	  more	  common	  than	  pairs	  with	  two	  ring-­‐containing	  amino-­‐acid	  side	  chains	  [38].The	  Phe	  404/His	  357	  pair	  in	  the	  PB2	  subunit	  of	  in^luenza	  virus	  polymerase	   is	   an	   interesting	   variant	   of	   this	   type	   of	   cap-­‐binding	  pocket	  since	  the	  benzyl	   ring	  of	  the	  Phe	  is	  tilted	  30°	   to	  the	   plane	  of	  the	  cap	  base	  and	  a	  histidine	  side	   chain	  acts	  as	  the	  second	  stacking	  group	  (Fig.	  1b).	  This	  latter	  feature	   is	  unusual	  even	  among	  different	  strains	  of	  in^luenza,	  since	  the	  PB2	  proteins	  of	  types	  B	  and	  C	   in^lu-­‐enza	  have	  Tyr	  at	  this	  position	  [34].PARN	   is	   the	   only	   m7G-­‐binding	   protein	   identi^ied	   thus	   far	   in	  which	   the	   canonical	   ‘cation-­‐-­‐sandwich’	   signature	   is	   absent,	   since	  the	   methylated	  m7G	   base	   stacks	   on	   a	   single	   tryptophan	   residue	  (Trp	   475)	   [26].	   Intriguingly,	   the	   solution	   structure	   of	   the	   PARN	  RRM	   complexed	  with	  m7GpppG	  shows	   that	   the	   second	  G	  can	  pro-­‐vide	  the	  top	  layer	  of	  the	  sandwich	  by	  stacking	  on	  the	  m7G	  [27,	  28].	  This	   variant	   of	   the	   cation-­‐-­‐type	   binding	   interaction	   may	   still	   ac-­‐count	   for	   the	   discrimination	   between	  methylated	   and	   unmethy-­‐lated	   ligands,	   as	   GTP	   was	   found	   to	   bind	   at	   least	   100-­‐fold	   more	  weakly	  than	  m7GTP	  [26].	  Another	  common	  characteristic	  of	  cap	  recognition	  is	  the	  forma-­‐tion	  of	  hydrogen	  bonds	  between	  nitrogen	  atoms	  N1	  and/or	  N2	  of	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the	   base	   and	   carboxylate	   groups	  of	  key	  acidic	   residues	   (Asp	  or	  Glu)	   in	   the	   cap-­‐binding	   pocket	   (Fig.	   1e).	   At	   least	   one	   essential	  acidic	   amino	  acid	   has	  been	   identi^ied	   in	  all	   the	   cap	  binding	   pro-­‐teins	  that	  exhibit	   the	   cap-­‐sandwich	  mode	   of	  binding.	  The	   impor-­‐tance	   of	   this	   interaction	   is	   demonstrated	   by	   the	   ^inding	   that	  
methylation	   at	   N2	  reduces	   the	   af^inity	  of	  CBC	  for	  m7G	  by	  about	  100-­‐fold	  [39].	  The	  PARN	  RRM	  also	  forms	  hydrogen	  bonds	  with	  the	  N1	  and	  N2	  atoms	  of	  the	  m7G	  but	  is	  again	  an	  outlier	  since,	  instead	   of	   acidic	   side	   chains,	   it	   deploys	   two	  backbone	  carbonyl	  groups	  to	  make	  the	  interac-­‐tions	  [26].The	  binding	  of	  the	  methyl	  group	  of	  m7G	  gener-­‐ally	  appears	  to	  be	   stabilised	   by	  van	   der	  Waals	  interaction	  with	  surrounding	   side	  chains	  and/or	  backbone	   atoms	  within	   the	   binding	   pocket	  [1].	   In	   the	   case	   of	  CBP20	   [17],	   evidence	   sug-­‐gests	   that	   direct	   interactions	   with	   the	   methyl	  moiety	   itself 	  are	   not	   important	   for	   speci^icity	  [17,	   34].	  Rather,	   it	   is	   likely	   that	   the	   most	   sig-­‐ni^icant	   impact	   of	   methylation	   is	   to	   enhance	  the	  cationic	  nature	  of	  the	  base,	  which	  strength-­‐ens	  the	  stacking	   interactions	  [40].	  Nonetheless,	  an	   interesting	   recent	   study	   has	   shown	   that	  modi^ication	   of	   the	   methyl	   group	   on	   N7	   can	  enhance	   the	   binding	   af^inity	   of	  m7G	   caps	  and	  may	   facilitate	   the	   development	   of	   eIF4E	   as	   a	  potential	  drug	  target	  in	  diseases	  such	  as	  cancer	  [41].The	  structural	  data	  reveal	   a	  number	  of	  interac-­‐tions	   with	   other	   features	   of	   the	   m7G	   cap,	  though	   their	  use	   varies	   between	   the	   proteins	  that	   have	   been	   investigated.	   For	   example	   ri-­‐bose	   hydroxyl	   moieties	   of	   the	   m7G	   are	  hydrogen-­‐bonded	   to	   the	   protein	   in	  CBP20	   but	  not	  in	  eIF4E,	  VP39	  or	  PB2	  where	   they	  are	   sol-­‐vent	  exposed	  [13,	  34,	  42].	  Interactions	  with	  the	  triphosphate	  moiety	  of	  the	   cap	  are	  more	   com-­‐mon,	  mostly	  involving	  Arg	   and	  Lys	  side	  chains,	  though	  the	  geometry	  of	  the	  interactions	  exhib-­‐its	   considerable	   variation	   [1,	   17,	   28,	   33,	   34,	  43].	  The	   crystal	   structure	   of	   snurportin1	   com-­‐plexed	  with	  m3GpppG	  revealed	  a	  distinct	  mode	  of	   cap	   binding	   from	   the	   proteins	   discussed	  above	  which	  seems	  likely	  to	  be	  due	  to	  the	  need	  to	  discriminate	   m3G	  from	  m7G	  caps	   [29]	   (Fig.	  1f).	   Like	   the	   cap-­‐binding	   domain	   of	   PARN,	  there	   is	  only	  a	   single	   aromatic	  amino-­‐acid	  side	  chain	  (Trp	  276)	   to	  provide	  a	   stacking	   interac-­‐tion	   with	   the	   m3G	  cap.	   Moreover,	   as	   in	   PARN	  [27,	  28],	  the	  cation-­‐π	  sandwich	  is	  completed	  by	  stacking	   the	   downstream	   G	   of	   the	   transcript	  onto	  the	  cap	  [29].	  The	   dimethylated	   N2	   group	   of	   the	   m3G	   cap	  packs	  against	  a	   second	  Trp	   residue	   (Trp	  107)	  which	  lies	  on	  the	   surface	  of	  snurportin1,	  perpendicular	  to	  Trp	  276	  (Fig.	  1f).	  This	   interaction	  is	  clearly	  important	   for	  speci^ic	  recogni-­‐tion	   of	   the	   m3G	  cap	  (which	  binds	   at	   least	   14-­‐fold	   tighter	  than	  an	  m7G	  cap)	  since	  the	  substitution	  of	  Trp	  107	  by	  Ala	  reduces	  the	  bind-­‐ing	  af^inity	  and	  renders	  the	  protein	  unable	  to	  distinguish	  m3G	  from	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Fig.	   1:	   Cap-­‐binding	   proteins	  are	   structurally	  diverse.	   Structures	   of	   (a)	  CBP20	  [17]	   (note	   that,	   for	  simplicity,	   the	   CBP80	  subunit	   is	   not	   shown),	   (b)	  In^luenza	   virus	  PB2	   [34],	   (c)	  eIF4E	   [45]	   and	   (d)	  snurportin1	   [29]	   are	   depicted.	   In	   each	   case	   the	   cap	  bound	   to	   the	   protein	   is	   depicted	   in	   a	   stick	  representation	  with	  atoms	  colour-­‐coded	  by	  type	   (C	  –	  grey;	  O-­‐	  red;	  N-­‐	  blue;	  P	  –	  orange;	  S	   -­‐	  yellow).	  The	   cap-­‐stacking	   residues	   are	   labelled.	   Close-­‐up	   views	   showing	   the	   details	   of	   cap-­‐binding	   are	  shown	   for	   (e)	  eIF4E	  and	  (f)	  snuportin1.	  Selected	  amino-­‐acid	  side	  chains	  are	  shown	  as	   sticks	  with	  atoms	  coloured	  by	  type	  as	  above	  except	  that	  carbon	  atoms	  take	  on	  the	  colour	  of	  the	  protein.
m7G	   [29].	   Although	   N2	   is	   modi^ied	   by	  methylation	   in	  m3G,	   the	  protein	  maintains	  a	  speci^ic	  hydrogen	  bond	  to	  the	  N1	  group	  of	  the	  cap	   (Fig.	  1f),	   an	  interaction	  that	   is	  observed	   in	  m7G	  cap-­‐binding	  proteins;	  however,	  the	  general	  conservation	  of	  hydrogen-­‐bonding	  groups	  in	  proteins	  that	  interact	  speci^ically	  with	  both	  the	  N1	  and	  N2	   groups	   of	  m7G	  caps	   (as	   shown	   or	   eIF4E	   in	   Fig.	   1e)	   explains	  their	  ability	  to	  discriminate	  against	  m3G-­‐capped	  U	  snRNAs.	  
2.3.	  	  Af]inity	  and	  speci]icity	  of	  the	  cap-­binding	  proteins.An	  intriguing	  and	  mysterious	  aspect	  of	  cap	  recognition	  is	  that,	  despite	   many	   evident	   similarities,	   the	   cap	   binding	   proteins	   dis-­‐cussed	  above	   have	  different	   af^inities	  for	  m7G	  caps.	  In	  particular,	  whereas	  the	  CBC	  and	  eIF4E	  bind	  m7G	  caps	  with	  nanomolar	  af^in-­‐ity,	   VP39,	   PARN,	   h4EHP	  and	   PB2	   have	   dissociation	   constants	   in	  the	   micromolar	   range.	   In	   the	   case	   of	   in^luenza	  virus	  PB2,	  it	   has	  been	  proposed	   that	   the	   imperfect	   aromatic	   sandwiching	   due	   to	  the	   smaller	  aromatic	  ring	  of	  His	  357	  may	  explain	   its	  lower	  bind-­‐ing	   af^inity	   and	   weaker	   discrimination	   between	   methylated	  m7GTP	   and	   unmethylated	   GTP	   [34].	   Quali^ied	   support	   for	   this	  notion	   comes	  from	   the	   ^inding	   that	   substitution	  of	  His	  357	  with	  Trp	  increases	  the	  PB2	  af^inity	  for	  the	  cap	  seven-­‐fold	  [34].	  Equally,	  the	   lower	   af^inity	   of	   PARN	   for	   the	   cap	   (micromolar	  Kd)	   may	   be	  due	   to	  the	   fact	   that	   the	   ‘cation-­‐π-­‐sandwich’	   interaction	   can	  only	  be	  completed	  by	  the	  RNA	  [27,	  28].	  It	   remains	  unclear	   why	  VP39	   and	  h4EHP	   have	  much	   lower	  af^inity	   for	   cap	   than	   eIF4E	   and	   CBC,	   even	   though	   they	  possess	  similar	  cap-­‐sandwiching	   residues.	  The	  200-­‐fold	  difference	   in	   cap	  af^inity	  between	  eIF4E	  and	  h4EHP	  is	  the	  most	  dif^icult	  to	  explain	  since	   their	   overall	   structures	   are	   extremely	   similar:	   the	   root-­‐mean-­‐square	   difference	   in	   Cα	   positions	   is	   only	  1	   Å	   [14].	   eIF4E	  uses	   a	   Trp/Trp	  aromatic	  pair	  to	   sandwich	  the	  m7G	  cap	  whereas	  4EHP	  has	  a	  Trp/Tyr	  pair;	  however,	  this	  variation	  does	  not	  corre-­‐late	   with	   af^inity	   and	   indeed	   mutation	   of	   eIF4E	   to	   a	   Trp/Tyr	  stacking	  pair	  had	  only	  a	  marginal	  effect	  on	   the	  cap-­‐binding	   af^in-­‐ity,	  actually	  enhancing	   it	  about	  1.5-­‐fold	  [11].	  Overall,	  the	  contacts	  that	   the	  methylated	  base	  makes	  with	  both	  proteins	  are	   remarka-­‐bly	  similar,	  with	  only	  minor	  differences	  in	   the	   connections	  made	  by	  the	  ribose	  and	  the	  triphosphate	  moieties.	  The	  main	  differences	  between	   the	   two	  structures	  occur	  in	   the	   N	  and	  C-­‐termini	  and	   in	  the	   1-­‐2	   loop	   which	   forms	   one	   wall	   of	   the	   m7GTP	   binding	   site	  pocket;	   this	   loop	   is	  marginally	  longer	   in	  4EHP	   and	   contains	   an	  additional	   short	   helix	   [14].	   Whether	   these	   can	   account	   for	   the	  large	  difference	  in	  binding	  af^inity	  remains	  to	  be	  determined.	  Interaction	  of	  5´	  capped	  mRNAs	  with	  the	  cap-­‐binding	  proteins	  may	  be	   affected	   by	  portions	  of	  the	   molecule	   downstream	   of	   the	  cap,	   though	   the	   particular	  features	  of	  the	  binding	   sites	  responsi-­‐ble	   for	  these	   effects	  are	   not	  entirely	  clear.	   For	   example,	  whereas	  PB2	  appears	   unable	   to	  discriminate	   between	  m7G	  and	  m7GpppG	  [34],	   the	   addition	   of	   the	   second	   guanosine	   impacts	   binding	   to	  eIF4E	   and	   the	   CBC,	   though	   in	   different	  ways.	  The	   CBC	  binds	   to	  m7GpppG	  with	  an	  af^inity 	  that	   is	  one	  to	  two	  orders	  of	  magnitude	  tighter	   than	   for	  m7GTP	   [39,	   44].	   The	   crystal	   structure	   suggests	  that	   the	   af^inity	  enhancement	  may	  arise,	  at	   least	   in	   part,	  by 	  the	  stacking	  of	  the	  second	  guanosine	  base	  on	  the	   conserved	  Tyr	  138	  (Fig.	   1a).	   However,	   this	   stacking	   interaction	   is	  not	   consistently	  observed	   in	   the	   four	   independent	   structures	   [17,	   18]	   and,	   fur-­‐
thermore,	   substitution	   of	   Tyr	   138	   by	  Ala	   only	  modestly	   reduces	  binding	  [17,	  39].	  Nor	   can	   the	   ^inding	   that	   m7GpppG	   binds	   10-­‐20	   times	   more	  weakly	  to	  eIF4E	  than	  m7GTP	  be	  de^initively	  explained	  by 	  crystallo-­‐graphic	  analysis	  since,	   although	   the	   co-­‐crystal	   structure	   of	   eIF4E-­‐m7GpppA	   shows	  that	   the	   downstream	   base	   (adenosine)	   interacts	  with	  a	  C-­‐terminal	  loop	  on	  the	  protein	  (residues	  203-­‐210)	   [45]	  (Fig.	  1c),	   in	   the	   crystal	   structure	   of	   the	   eIF4E-­‐m7GpppG	   complex	   the	  second	  base	  is	  disordered	  [43].	  It	  may	  be	  that	  variations	  in	  crystal	  contacts	   are	   responsible	   for	   the	   different	  structural	   results,	   a	   po-­‐tential	   artefact	   of	   the	   method	   that	   can	  complicate	   the	   interpreta-­‐tion	   of	  crystal	   structures,	  particularly	  for	  parts	  of	  ligands	  that	   are	  situated	  on	  the	  periphery	  of	  the	  protein	  structure.	  
2.4.	  	  Regulation	  of	  cap	  binding	  proteins.	  The	   dif^iculties	   discussed	   above	   highlight	   some	   of	   the	   limita-­‐tions	   of	   our	   current	   understanding	   of	   the	   structural	   basis	   of	   cap	  recognition.	  But	   the	   picture	   is	  more	   complex	   still	   since	   additional	  protein	   co-­‐factors	   that	   associate	  with	  cap-­‐binding	  proteins	   in	  vivo	  may	  also	  impact	  on	  their	  binding	   af^inity.	  At	  one	  end	   of	   the	   spec-­‐trum,	  CBP20	  appears	  to	  bind	  the	  cap	  only	  in	  the	  presence	  of	  CBP80	  [19],	   even	   though	   the	   larger	  subunit	  makes	   no	  direct	   interactions	  with	  the	  RNA	  [17,	  18].	  The	  effect	  appears	  to	  be	   cooperative:	   in	  the	  absence	  of	  cap,	  only	  the	  core	  RRM	  domain	  of	  CBP20	  (residues	  33-­‐125)	  is	  ordered	  but,	  upon	  cap	  binding,	  Tyr20	  within	  the	  N-­‐terminal	  extension	  of	  CBP20	  takes	  up	  a	  position	  as	  the	  top	  layer	  of	  the	  aro-­‐matic	  sandwich	  and	  secures	  the	  cap	  in	  place	  [17,	  18]	  (Fig.	  1a).	  This	  interaction	   appears	   to	   favour	   general	   stabilisation	   of	   the	   N-­‐terminus	  of	  CBP20,	  which	  adopts	  an	  extended	  conformation	  lying	  across	   the	   upper	   surface	   of	   the	   CBP80	   subunit.	   The	   binding	   of	  some	  capped	  RNAs	  to	  the	  CBC	  may	  also	  be	   regulated	  by	  other	  fac-­‐tors.	  For	  example,	  the	  export	  of	  certain	  capped	  U	  snRNAs	  by	  asso-­‐ciation	  with	  the	  CBC	  is	  dependent	  on	  the	   protein	   co-­‐factor	  PHAX,	  which	   associates	  with	  CBC	  and	   has	  an	  RNA	  binding	   domain	   [46].	  Conceivably	  PHAX	  may	  bind	  to	  the	  RNA	  downstream	  of	  the	  cap	  and	  thereby	  in^luence	  the	  binding	  of	  the	  cap	  to	  CBP20.	  In	  contrast	  to	  CBP20,	  VP39	  and	  PB2	  can	  bind	  to	  the	  m7G	  cap	  as	  isolated	   polypeptides	   even	   though	   they	  are	   associated	  with	  other	  proteins	   in	  vivo	  that	  may	  regulate	   cap	  binding	   [1].	  Recent	  studies	  on	   the	   polymerase	   from	   in^luenza	   virus	  suggest	   there	   may	  be	   al-­‐losteric	  communication	  between	  the	   PB2	   and	  the	   PB1	  and/or	  PA	  subunits,	   that	   could	   explain	   the	   functional	   cooperativity	  observed	  between	   binding	   of	   the	   3´	   and	   5´ 	   ends	   of	   viral	   RNA	   and	   cap-­‐snatching	  from	  host	  mRNAs	  (see	  [47]	  and	  references	  therein).The	  most	  intensively 	  studied	  case	  of	  regulation	  of	  cap	  binding	  through	  interactions	  with	  other	  proteins	  centres	  on	  eIF4E	  [7].	  Both	  eIF4G	  and	  regulators	  such	  as	  4E-­‐BP1	  are	   reported	  to	  enhance	   the	  af^inity	  of	  eIF4E	  for	  m7G	  caps,	  though	  the	  precise	  magnitude	  of	  the	  observed	  effect	  varies	  between	  different	  laboratories	   [48-­‐51].	  The	  strongest	  effects	  have	   been	   obtained	  with	  m7G-­‐capped	  mRNA;	   for	  example,	  it	  has	  been	  shown	  that	  4E-­‐BP1	  can	  retard	  the	  rate	   of	  dis-­‐sociation	  of	  eIF4E	  from	  m7G-­‐capped	  mRNA	  by	  about	  two	  orders	  of	  magnitude	  [50].	  What	   is	   the	   structural	   basis	   for	   this	   apparent	   cooperativity?	  Solution	  and	   crystal	   structures	  of	  apo-­‐eIF4E	   [15,	  52,	  53]	  revealed	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considerable	   structural	   ^lexibility	  in	   the	   surface	   loops	  surround-­‐ing	   the	   cap-­‐binding	   site	   and	   on	   the	   dorsal	   surface	   that	   binds	  eIF4G	  and	  4E-­‐BP1	  [54,	  55].	  Most	  strikingly	  Trp	  56	  and	  Trp	  102,	  which	   sandwich	   the	  m7G	  cap	   in	  eIF4E	   [13,	   56],	   are	   both	  ^lipped	  outwards	  in	   the	  absence	   of	  ligand	  [13,	  15,	  52,	  53].	  This	  ^lexibility	  is	   likely	   to	   mediate	   allosteric	   communication	   between	   the	   cap-­‐binding	   site	   and	   the	   back	  of	   eIF4E,	   allowing	   eIF4G	  and	   4E-­‐BP1	  (and	   its	  homologues)	   to	   enhance	   cap-­‐binding	   [48,	  49,	   51].	   Both	  proteins	   interact	   with	   eIF4E	   via	   a	   conserved	   core	   motif	  (Tyr‑X‑X‑X‑X‑Leu‑Φ,	  where	  X	  is	  any	  amino	  acid	  and	  Φ	  is	  Leu,	  Met	  or	  Phe);	  however,	  binding	  of	  short	  peptides	  containing	   this	  motif	  is	   insuf^icient	   to	  enhance	   the	   af^inity 	  of	   eIF4E	   for	   cap	   [43,	   51].	  This	  observation	  is	  consistent	  with	  structural	  analyses	  that	  show	  that	   peptide	   fragments	   containing	   this	  motif	   bind	   to	   the	   dorsal	  surface	   of	   cap-­‐bound	   eIF4E	   structures	   but	   cause	   no	   signi^icant	  conformational	  changes	  [13,	  54].	  Strikingly,	  the	  solution	  structure	  of	  a	  yeast	  ternary	  complex	  formed	  from	  m7GDP,	  full-­‐length	  eIF4E	  and	   a	   fragment	   of	   eIF4G	   (393-­‐490)	   revealed	   highly	  cooperative	  folding	   of	  the	  N-­‐terminus	   of	   eIF4E	   and	   the	   eIF4G	  domain.	  This	  resulted	  in	  a	  much	   larger	  binding	   interface	  between	  the	   two	  pro-­‐teins	  which	  clearly	  offers	  scope	   for	  greater	  allosteric	  impact	  [57].	  However,	  the	  precise	  structural	  differences	  at	  the	  cap-­‐binding	  site	  are	  dif^icult	  to	  discern,	  in	  part	  because	  the	  high	  molecular	  weight	  and	   poor	  solubility	  of	  complex	   limited	  the	  accuracy	  of	   the	   struc-­‐ture	  determination,	  making	   it	  dif^icult	  to	  compare	  in	  meaningful	  detail	   with	   the	   eIF4E-­‐m7GDP	  binary	  complexes	  [12,	  13,	  57].	  The	  amino	   acids	   that	   form	   the	   eIF4E-­‐eIF4G	  interface	   are	   quite	   well	  conserved	   between	   yeast	   and	  mammals:	   in	   eIF4E,	   28/30	   inter-­‐face	   amino	   acids	   are	   similar,	   though	   for	   eIF4G	   this	  ratio	   is	  only	  12/29	   [57].	  While	   it	  is	  possible	   that	   a	   similar	  eIF4E-­‐eIF4G	  com-­‐plex	  may	  form	   in	  mammals,	  this	  has	  not	  yet	  been	  demonstrated;	  initial	  hints	  suggest	  that	  the	  nature	  of	  the	  interaction	  may	  actually	  be	  different	  [58].	  Moreover,	   it	   is	  not	  clear	  whether	  binding	   of	   the	   mammalian	  4E-­‐BPs	   induces	  a	   similar	  co-­‐folding	   of	  the	  N-­‐terminus	   of	   eIF4E.	  Although	   they	  are	   a	   similar	  size	   to	  the	   eIF4E-­‐binding	   domain	  of	  eIF4G	   (~110	   amino	   acids)	   and	   have	   the	   conserved	   heptameric	  binding	   motif,	   4E-­‐BPs	   are	   otherwise	   unrelated	   in	   sequence	   to	  eIF4G.	  So	   far	  structural	   work	   has	  been	   con^ined	   to	  peptides	   de-­‐rived	   from	   4E-­‐BP1	   that	   contain	   the	   core	   binding	   motif	   but	   are	  only	  17	  or	  34	  amino	  acids	  long	  and	  do	  not	  enhance	  cap	   binding	  [54,	  55].	  The	  structures	  formed	  in	  each	  case	  are	   very	  similar;	  use	  of	  the	  longer	  peptide	  revealed	  no	  signi^icant	  additional	  structural	  details	   and	   gave	   no	   hint	   of	   a	   possible	   co-­‐folding	   mechanism.	   It	  seems	  likely	  that	  the	  allosteric	  mechanism	  of	  4E-­‐BPs	  differs	  from	  that	   of	   eIF4G,	  but	   further	  work	   is	   necessary	  to	  support	   this	  no-­‐tion.More	  recent	  results	  have	  clouded	  the	  picture	  and	  suggest	  that	  additional	   factors	  may	  in^luence	   cap	  binding	   by	   eIF4E.	   A	  study	  using	   human	   proteins	   found	   that	   binding	   of	   eIF4G(557-­‐646)	  (which	  is	  equivalent	  to	  the	   fragment	  used	  in	   the	   yeast	   complex),	  did	   not	   consistently	  enhance	   binding	   of	  m7GpppG	  to	  eIF4E	   [59];	  an	   enhancement	   effect	  of	   the	   eIF4G	  domain	   was	  only	   observed	  with	   recombinant	   eIF4E	   expressed	   in	   E.	   coli	   that	   had	   been	   re-­‐folded	   after	   puri^ication	   from	   inclusion	   bodies.	   This	   echoes	   an	  earlier	   report	   that	   the	   puri^ication	   protocol	   used	   for	   eIF4E	   can	  drastically	   affect	   binding	   measurements	   [43]	   and	   suggests	   that	  
preparation	   methods	   will	   need	   careful	   consideration	   in	   future	  work.	   A	   separate	   investigation	   that	   also	   used	   human	   proteins	  showed	  that	  eIF4G	  only	  stimulated	  cross-­‐linking	  of	  cap	   to	  eIF4E	   if	  the	  RNA-­‐binding	  domain	  of	  eIF4G	  was	  present	  [58].	  Although	   this	  result	   contradicts	   earlier	  reports	  that	  yeast	  eIF4G	  fragments	   lack-­‐ing	  any	  RNA	  binding	  activity	  could	   enhance	   cap-­‐binding	  by	  eIF4E	  [51]	  and	  needs	  to	  be	   con^irmed	  using	   techniques	  that	  probe	  bind-­‐ing	  af^inity	  more	   directly,	   it	   reasserts	  the	  possibility	   that	   (as	  with	  CBC)	   association	  of	   the	   complex	   with	   the	   downstream	   RNA	  may	  assist	  with	  binding	  of	  cap	  to	  eIF4E.	  Although	  our	  understanding	  of	  5´ 	  cap	  recognition	  has	  advanced	  enormously	   as	   a	   result	   of	   detailed	   structural	   investigations	  and	  af^inity	  measurements,	  there	  are	  still	  many	  interesting	  questions	  to	  answer,	  particularly	  with	  regard	  to	  dissecting	   the	   ^ine	   detail	  of	  co-­‐factor	   and	  RNA	  modulation	   of	   cap	  binding.	  Tackling	   these	   prob-­‐lems	  will	   present	  stiff	  challenges	  but	  is	  likely	  to	  produce	  structural	  insights	  that	  will	  relate	  more	  closely 	  to	  the	  in	  vivo	  function	  of	  these	  cap-­‐binding	  proteins.
3.	  	  Speci<ic	  recognition	  of	  RNA	  3´-­ends	  by	  La	  and	  NSP3	  Whereas	   5´	   cap	   recognition	   depends	   largely	   on	   interactions	  with	   a	   single	   modi^ied	   nucleotide,	   the	   best	   known	   examples	   of	  speci^ic	  recognition	  of	   the	   3´	  ends	  of	  RNA	  involve	   protein	  interac-­‐tions	   with	   a	   short	   stretch	   of	   nucleotides	   in	   a	   sequence-­‐speci^ic	  manner.	  Structural	  studies	  have	  revealed	  some	  interesting	  similari-­‐ties	  and	  differences	  between	  the	  mode	  of	  binding	  of	  the	  3´-­‐termini	  of	  RNA	  by	  two	  unrelated	  proteins,	  the	  human	  La	  protein	  and	  rota-­‐virus	  NSP3.	  A	  further	  interesting	  example,	  binding	   of	  PAZ	  domains	  to	  the	   3´	  ends	   of	   interfering	   RNAs,	  will	   be	   considered	  in	   the	   next	  section.
3.1.	  	  Recognition	  of	  RNA	  3´	  ends	  by	  La.	  The	   eukaryotic	   La	   protein	   is	   predominantly	   localised	   in	   the	  nucleus	  of	  eukaryotic	  cells	   [60,	   61]	   where	   it	   aids	   processing	   and	  maturation	   of	   non-­‐coding	   RNA	  transcripts.	   In	   metazoans	   it	   binds	  speci^ically	   to	   the	   UUU-­‐OH	   sequences	   found	   at	   the	   3´ 	  termini	  of	  RNA	  polymerase	   III	  RNA	  transcripts,	   including	   pre-­‐tRNA,	  5S	   RNA	  and	   SRP	   RNA,	   [62-­‐64].	   In	   yeast	   cells,	   La	   binds	   to	   the	   3´	   poly(U)	  ends	   of	  RNA	   polymerase	   II	   transcripts,	   such	   as	  snRNAs,	   that	   are	  generated	   by	   endonucleolytic	   processing	   [65,	   66].	   The	   primary	  function	   of	   the	   protein	   is	   to	   protect	   the	   3´-­‐termini	  of	   these	   tran-­‐scripts	  from	  digestion	  by	  3´-­‐5´	  exonucleases	  [63,	  67],	  though	  it	  has	  additional	  roles	  in	  regulating	  RNA	  maturation	  pathways	  and	  aiding	  assembly	  of	  the	   transcripts	  into	  functional	  RNA-­‐protein	  complexes	  [64,	  66-­‐70].The	  La	  protein	  is	  modular	  in	  construction.	  Human	  La	  contains	  a	  La	  motif	  and	  two	  RRMs	  in	  its	  N-­‐terminal	  half	  and	  an	  unstructured	  C-­‐terminal	  region	  [60,	  61,	  71,	  72].	  Yeast	  La	  has	  a	  somewhat	  simpler	  form	   that	   lacks	   the	   second	  RRM	   [60].	   The	  ability	  to	  bind	   3´-­‐UUU-­‐OH	   sequences	   is	  nevertheless	  retained	  across	  these	   species	  since	  this	   function	   is	   performed	   by	   the	   common	   N-­‐terminal	   domain	  (LaNTD;	  residues	  1-­‐194)	  that	  contains	  the	  La	  motif	  and	  RRM1	  [71,	  73].
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The	   crystal	  structures	  of	  human	  LaNTD	  bound	  to	  a	  variety	  of	  RNAs	   (all	   terminating	   with	   at	   least	   three	   U’s)	   show	   a	   common	  mode	   of	  binding	   that	  nevertheless	  displays	  an	   interesting	   degree	  of	  plasticity	  [74,	  75].	  The	  two	  domains,	  which	  are	  connected	  by	  a	  ^lexible	  linker	  in	  solution	  [71],	  clamp	  onto	  the	   3´-­‐end	  of	  the	  RNA,	  forming	   a	   sequence-­‐speci^ic	  pocket	  at	  the	   inter-­‐domain	  cleft	  [74,	  75]	   (Fig.	  2a).	  The	   bound	   RNA	  3´-­‐end	   adopts	   a	   tight	   turn	   that	   is	  generally	  stabilised	   by	   the	   stacking	   of	   U-­‐3	   onto	  U-­‐1	   (nucleotides	  are	   numbered	   negatively	   starting	   with	   U-­‐1	   at	   the	   3´-­‐end),	   both	  bases	  only	  making	   contact	  with	   the	   La	  motif.	  U-­‐2	   is	   splayed	  out	  away	   from	   this	   stacked	   pair	   and	  contacts	  both	  the	   La	   motif	   and	  RRM1	  domains.	  
This	   mode	   of	   binding	   was	   initially	   ob-­‐served	   for	   duplex	   RNA	   with	   a	   three-­‐uridylate	   overhang	   at	   the	   3´-­‐end	   that	  formed	  unexpectedly	  during	  crystallisation	  [75].	   Subsequent	   studies	   showed	   that	   the	  presence	   of	  the	   duplex	   prevented	   the	   two	  domains	   from	   clamping	   down	   completely	  on	   the	   RNA	  3´-­‐terminus;	   co-­‐crystallisation	  with	   purely 	   single-­‐stranded	   RNA	   ligands	  allowed	   a	   closer	  approach	  of	  the	   La	   motif	  to	   RRM1	   and	   the	   formation	   of	   fully 	   inti-­‐mate	  contacts	  with	  the	  RNA	  [74].	  Although	  the	   overall	   U-­‐turn	   conformation	   was	   re-­‐tained,	   there	   were	   signi^icant	  adjustments	  of	   the	   RNA	   ligand	   that	   resulted	   in	   full	   —	  rather	   than	   offset	  —	  stacking	   of	  U-­‐3	   on	  U-­‐1	  and	   formation	   of	   additional	   interactions	  with	   the	   protein.	   Perhaps	   surprisingly,	  given	   the	   high	   af^inity	   of	   the	   interaction	  with	   RNAs	   ending	   in	   oligo(U)	   sequences	  (KD	  ~	  20	  nM	   for	  human	  LaNTD	  -­‐	  [74,	  75]),	  the	   binding	   cleft	   remains	   rather	   open.	   In	  the	   complex	   of	   LaNTD	   with	   a	   AUUUU	  oligomer	   this	   openness	   was	   observed	   to	  allow	   an	  alternative	   binding	   conformation	  of	   the	   3´-­‐end	   of	   a	   single-­‐stranded	   RNA	  ligand	  in	  which	  U-­‐4	   rather	  than	  U-­‐3	   stacked	  onto	  the	  U‑1	   nucleotide	   at	   the	   3´-­‐end.	  This	  arrangement	  involves	  a	  wider	  U-­‐turn	  at	  the	  3´-­‐end	   in	   which	   U‑3	   ^lips	   out	   towards	  RRM1,	  but	  does	  not	  make	  any	  contact	  with	  it	  [74].	  Curiously,	  in	  view	  of	  the	  well-­‐characterised	  speci^icity	  of	  La	  for	  the	  UUU-­‐OH	  3´-­‐ends	  of	  RNA,	   the	   network	   of	  base-­‐speci^ic	   interac-­‐tions	  with	  the	  protein	  is	  less	  extensive	  than	  one	   might	   expect	   (Fig.	   2b).	   U-­‐1	   interacts	  exclusively	  with	   the	   La	   motif,	   which	   only	  makes	   speci^ic	   polar	   contacts	   with	   the	  backbone	  of	  the	   nucleotide.	  The	  2´	  and	  3´-­‐OH	   groups	   from	   the	   ribose	   ring	   of	  U-­‐1	   are	  speci^ically	  recognised	  by	  hydrogen	  bonds	  to	   the	   side-­‐chain	  carboxylate	   of	  Asp	   33,	  a	  key	   residue	   in	   the	   binding	   site	   [73,	   75],	  while	  the	  U-­‐1	  phosphate	  group	  makes	  three	  hydrogen	  bonds	  to	  the	  La	  motif.	  The	  U-­‐1	  base	   stacks	  directly	  onto	  the	  aromatic	  side	  chain	  of	  Phe	  35.	  Although	  it	  packs	  closely	  enough	  to	  make	   contacts	  with	  the	   body	  of	   the	   La	   motif,	   there	   are	   no	   base-­‐speci^ic	   interactions	  with	  the	  protein.	  Consistent	  with	  this	  structural	  observation,	  varia-­‐tion	   of	   the	   terminal	   base	   only	  reduced	   the	   binding	   af^inity	   very	  modestly	  [75].	  The	   penultimate	  nucleotide,	  U-­‐2,	  makes	   intimate	   contacts	  with	  both	  the	  La	  motif	  and	   RRM1	   in	   the	   deepest	   recess	  of	  the	  binding	  cleft;	   in	   striking	   contrast	   to	   U-­‐1,	   it	   is	   the	   nucleotide	   base	   of	   U-­‐2	  rather	   than	   the	   backbone	   that	  makes	  speci^ic	   hydrogen	  bonds	  to	  the	   LaNTD	   (Fig.	  2b).	  The	   O2	  and	   O4	   atoms	   of	   the	   U-­‐2	   pyrimidine	  ring	   hydrogen	   bond	   to	   the	   side-­‐chain	   amide	  of	  Gln	  20	  (La	   motif)	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Fig.	   2:	  Contrasting	  binding	   sites	  in	  La	   and	   rotavirus	  NSP3	  for	  RNA	   3´	  ends.	   (a)	  Surface	   representation	  of	   LaNTD	   complexed	   with	   the	   RNA	   oligomer	   AUAAUUU	   [74].	   The	   protein	   is	   coloured	   by	   domain	  (Green	  –	  La	  motif;	  light-­‐orange	  –	  RRM1).	   The	  RNA	   is	  shown	  as	  sticks,	  colour-­‐coded	  by	  atom-­‐type	   as	  in	  Figure	   1;	   for	   clarity	   the	   ^irst	   three	   bases	   are	   omitted.	   Arrows	   indicate	   the	   location	   of	   the	   canonical	  RNA	   binding	   surfaces	   on	   the	   La	   motif	   and	   RRM	   domains.	   (b)	  Close-­‐up	   view	   of	   LaNTD-­‐RNA	   interac-­‐tions	  for	   the	   3 	´   terminal	  three	   bases	  of	  AUAAUUU	  [74]	   in	  the	   same	   orientation	  as	   panel	  a.	   Hydrogen	  bonds	  are	   shown	  as	  grey	  dashed	   lines.	   (c)	  Surface	   representation	   of	   the	   rotavirus	   NSP3	  dimer	   com-­‐plexed	  with	   the	   RNA	   oligomer	   GUGACC	   [82].	   (d)	   Close-­‐up	   view	   of	   the	   NSP3-­‐RNA	   interactions	   in	   the	  same	   orientation	  as	  panel	  c.	  The	   ^irst	  base	   of	  the	   RNA	  was	  disordered	   and	  not	   included	   in	  the	   re^ined	  model	  [82].	  
and	  the	  main-­‐chain	  amide	  of	  Ile	  140	  (RRM1).	  The	  pyrimidine	  ring	  of	  U-­‐2	   is	  pinned	  between	  Tyr	  23,	  a	   La	  motif	   residue,	  and	   the	   hy-­‐drophobic	  side	   chain	   of	   Leu	   124,	   an	   arrangement	   that	   partially	  recapitulates	   the	   sandwiching	  mode	   of	   base	   recognition	   seen	   in	  cap-­‐binding	   proteins	  (see	  above).	  It	   is	  evident	   from	   the	   structure	  that	  the	  speci^ic	  recognition	  of	  U-­‐2	  arises	  from	  a	  cooperative	  set	  of	  protein-­‐RNA	  and	   protein-­‐protein	   interactions	   involving	   residues	  from	   both	   domains	   to	   form	   a	   tightly	  de^ined	   pocket	   that	   is	   tai-­‐lored	  in	  size,	  shape	  and	  hydrogen-­‐bonding	  capacity	  for	  a	  uridylate	  base	   (Fig.	  2a,b).	  This	  induced	  ^it	  of	  the	   binding	  pocket	  around	  U-­‐2	  accounts	  well	   for	  the	  cooperative	   nature	   of	  RNA	  binding	  by	  both	  domains	  of	  LaNTD	  [71,	  73,	  76,	  77].	  Either	  U-­‐3	  or	  U-­‐4	   appears	  able	   to	  stack	  on	   U-­‐1	   to	  stabilise	   the	  tight	  turn	  at	   the	   end	  of	  the	   bound	  RNA	  (see	   above).	  This	  stacked	  base	   is	  also	  held	  in	  place	  by	  base-­‐speci^ic	  hydrogen	  bonds	  involv-­‐ing	  the	  02	  and	  N3	  atoms	  to	  the	  backbone	  of	  the	  La	  motif	  [74]	  (Fig.	  2b).	  The	   crystal	   structures	  of	  LaNTD	  complexes	  with	  RNA	  ligands	  having	   3-­‐8	   uridylates	   at	   the	   3´-­‐end	   are	   consistent	  with	   binding	  measurements	  from	  several	   laboratories.	  The	  particular	  contacts	  observed	   between	   the	   proteins	   and	   U-­‐1-­‐U-­‐4	   (depending	   on	   the	  structure)	  account	  readily	  for	  the	   observation	  that	  3-­‐4	  uridylates	  are	  needed	  for	  optimal	  binding	   af^inity	  [75,	  78,	  79].	  However,	  it	  is	  clear	   that	   these	   do	   not	   contribute	   equally	   and	   in	   fact,	   although	  modest	   reductions	   in	   binding	   af^inity	   (1.5	   to	   3.3-­‐fold)	   are	   ob-­‐served	  following	  substitutions	  of	  U-­‐1,	  U-­‐3	  or	  U-­‐4,	  mutation	  of	  U-­‐2	   is	  much	  more	  deleterious,	  reducing	  the	  af^inity	  by	  up	  to	  14-­‐fold	  [74,	  75].	  It	  is	  clear	  that	  U-­‐2	   is	  the	  primary	  source	  of	  binding	  energy;	  the	  structures	   reveal	   that	   this	   arises	   because	   it	   occupies	   the	   most	  enclosed	  portion	  of	  the	   binding	   cleft	  making	  numerous	  polar	  and	  non-­‐polar	  contacts	  with	  the	  La	  motif	  and	  RRM1.	  Conceivably,	  the	  requirement	   for	  uridylate	   as	   the	   penultimate	   base	   at	   the	   3´-­‐end	  may	  be	  suf^icient	  to	  select	  from	  the	  pool	  of	  nuclear	  RNAs	  only	  that	  subfraction	  with	  oligo(U)	  sequences	  at	  the	  3´	  end.A	  particularly	  surprising	  aspect	  of	  the	  mode	  of	  binding	  of	  RNA	  3´	   ends	   to	   LaNTD	   is	   that	   neither	   of	   the	   canonical	   nucleic	   acid	  binding	   surfaces	  of	  either	   the	   La	  motif	   or	  RRM1	  (Fig.	   2a)	   is	   in-­‐volved	  in	  RNA	  contacts	  [74,	  75].	  This	  leaves	  these	  surfaces	  free	   to	  interact	  with	  other	  portions	  of	  the	  RNA	  ligand.	  Intriguingly,	  recent	  evidence	  suggests	  that	   the	  β-­‐sheet	  of	  RRM1	  may	  have	  an	   impor-­‐tant	   role	  in	  the	  chaperone	  activity	  of	  La	  by	  stabilising	   the	  confor-­‐mation	  of	  pre-­‐tRNA	  molecules	  that	  bind	  to	  the	  protein	  via	  their	  3´	  termini	  [80,	  81].	  
3.2.	  	  Recognition	  of	  RNA	  3´	  ends	  by	  rotavirus	  NSP3.	  Rotavirus	   NSP3	   (non-­‐structural	   protein	   3)	   also	   speci^ically	  recognises	  a	   short	  sequence	   at	  the	  3´	  end	  of	  RNA.	  Although	   it	  op-­‐erates	   in	   a	   different	  biological	   context	   to	  La	   and	  has	  a	   different	  structure,	  there	  are	  some	  interesting	  functional	  parallels	  between	  the	   two	  proteins.	  Rotaviruses,	   the	  major	   cause	   of	  gastroenteritis	  in	  children,	  have	   an	  11-­‐segment	  dsRNA	  genome	   contained	  within	  a	   layered	   protein	   capsid.	   The	   mRNA	  transcripts	   of	   the	   genomic	  segments	  have	  a	  5´	  cap	  structure	  but	  otherwise	  differ	  signi^icantly	  from	  normal	   eukaryotic	  mRNAs	  in	  that	  they	  lack	  a	  3´	  poly(A)	  tail.	  Instead	   the	   mRNAs	   have	   a	   conserved	   tetranucleotide	   sequence	  
that	  is	  speci^ically	  bound	  by	  NSP3,	  a	  functional	  homolog	  of	  poly(A)	  binding	   protein	   (PABP).	   Like	   PABP,	   rotavirus	   NSP3	   may	   enable	  tethering	   of	   the	   3´	   and	   5´	   ends	   of	   the	   mRNAs	   by	  binding	   to	   the	  eIF4G	  component	  of	  the	  cap-­‐binding	  complex	  and	  thereby	  facilitat-­‐ing	  translation	  [82],	  although	  it	  is	  not	  yet	  clear	  whether	  the	  protein	  actually	  plays	   this	  role	   in	   infected	  cells	   [83].	   Other	  functions	  may	  be	  more	   important:	  for	  example,	  by	  competing	  with	  PABP	  for	  bind-­‐ing	  to	  eIF4G,	  NSP3	  may	  also	  help	  to	  down-­‐regulate	  host	  cell	  protein	  synthesis	   [83].	   It	  has	   also	  been	   suggested	  that,	   like	   La,	  NSP3	   per-­‐forms	   a	   protective	   role,	   shielding	   3´-­‐termini	   from	   exonucleases	  [82].	  NSP3	   from	   group	   A	   rotavirus	   interacts	   speci^ically	   with	   the	  GACC	   sequence	   found	   at	   the	   3´	   end	   of	   the	   viral	   mRNAs.	   The	   N-­‐terminal	   domain	   (residues	  1-­‐170)	   is	   responsible	   for	  RNA	  binding	  while	  the	  C-­‐terminal	   domain	  binds	  to	  eIF4G	  [82].	  Crystallographic	  analysis	  of	  the	  N-­‐terminal	   fragment	  of	  NSP3	  complexed	  with	  a	  GU-­‐GACC	   hexanucleotide	   revealed	   that	   the	   protein	   forms	   a	   highly	  asymmetric	   homodimer	   containing	   a	   deep	   central	   binding	   cleft	  that	   accommodates	   the	   last	   four	  nucleotides	   at	   the	   3´	   end	   of	   the	  RNA	  [82]	  (Fig.	  2c).	  Differential	  scanning	  calorimetry	  (DSC)	  showed	  that	   RNA	  binding	   is	   associated	  with	   signi^icant	  thermal	   stabilisa-­‐tion	   of	   the	   protein	  —	   the	  melting	   temperature	   is	  raised	   by	   20°C.	  Since	  the	  structure	  shows	  that	  the	  RNA	  ligand	  could	  not	  dissociate	  without	   distortion	   of	   the	   binding	   pocket,	   the	   DSC	   result	   implies	  that	  conformational	  changes	  in	  the	  protein	  are	  involved	  in	  securing	  a	   tight	   interaction	  with	   the	   RNA	   ligand.	  This	  echoes	   the	   mode	   of	  binding	  of	  La	  to	  the	  3´	  ends	  of	  its	  RNA	  ligands,	  though	  in	   that	  case	  rigid	   body	  motions	   of	   the	   two	  component	   domains	  are	   primarily	  responsible	  for	  locking	  onto	  the	  RNA.In	  contrast	  to	   La	   the	   RNA-­‐binding	  cleft	   in	  NSP3	  is	  enclosed	  so	  that	   all	   four	   nucleotides	   of	   the	   binding	   sequence	   are	   largely	  shielded	   from	   solvent	   and	   the	   bases	   all	   make	   sequence-­‐speci^ic	  interactions	  with	  the	  protein	  (Fig.	  2c,d).	  The	  3´	  terminal	  nucleotide	  is	  accommodated	  in	  the	  deepest	  part	  of	   the	  pocket.	  As	  in	  La,	  both	  the	   2´	  and	   3´-­‐OH	   groups	  are	   close-­‐packed	   to	   the	   protein	  and	   in-­‐volved	  in	  speci^ic	  hydrogen	  bonds	  (in	  this	  case	  to	  the	  side	  chains	  of	  Asp	   100	   and	  Arg	   105	  –	  Fig.	   2d)	   —	   explaining	   the	   speci^icity	   for	  ligands	  with	   a	   free	   3´	   end.	   In	   addition	   to	   base-­‐speci^ic	   contacts,	  there	   are	   hydrogen	  bonds	   to	  all	   ^ive	   of	  the	  phosphate	  groups	  pre-­‐sent	   in	  the	   ligand	  and	   to	   each	  of	  the	   four	  2´-­‐OH	   groups	   of	  the	   te-­‐tranucleotide	  sequence.	  Moreover,	  the	  bases	  of	  the	  tetranucleotide	  ^it	  snugly	  into	  the	  binding	  pocket,	  making	  many	  van	  der	  Waals	  and	  stacking	   interactions.	   The	   RNA	   backbone	   is	   relatively	   extended	  compared	  to	  the	  RNA	  ligands	  of	  La,	  though	  there	  is	  one	  kink	  due	  to	  base-­‐stacking	  of	  the	  nucleotides	  in	  the	  -­‐3	  and	  -­‐4	  positions.	  It	   is	  curious	  that	   despite	   binding	   a	   similar	   number	  of	  nucleo-­‐tides	   in	   a	  much	  more	  enclosed	  pocket	   than	   found	   in	  LaNTD,	   the	  af^inity	  of	  NSP3	  for	  its	  cognate	  RNA	  is,	  if	  anything,	  slightly	  weaker	  (KD	   ~	  70	  nM)	   [82].	  This	  may	  re^lect	   the	   energetic	  cost	   of	  the	  con-­‐formational	   rearrangements	   of	   the	   protein	   that	   are	   involved	   in	  stabilising	  the	  bound	  conformation.
4.	  	  RNAi	  –	  Argonaute	  proteins.	  Novel	  modes	  of	  recognition	  of	  RNA	  termini 	  have	  been	  revealed	  in	  structural	  studies	  of	  Argonaute	   (Ago)	  proteins	  which	  bind	  both	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the	  5´	  and	  3´	  ends	  of	  single-­‐stranded	  RNA	  molecules	  to	   form	   the	  functional	   core	   of	  macromolecular	  complexes	  that	  are	   ultimately	  responsible	   for	  RNA	  interference	  (RNAi),	  a	  multi-­‐faceted	  mode	  of	  gene	   silencing	   found	   in	  all	   eukaryotes.	   RNAi	  can	   suppress	   gene	  expression	  directly,	  either	  by	  cleaving	  or	  ‘slicing’	  mRNA	  molecules	  or	  by	  repressing	   their	   translation	   into	   protein.	  Other	  modes	  of	  interference	   can	   induce	   transcriptional	   silencing	   or	   repress	  transposons.	  This	  topic	  has	  been	  covered	  in	  great	  detail	   in	  a	  num-­‐ber	  of	  recent	   reviews	   [3,	   7,	   84-­‐87]	   and	  the	   reader	  is	   referred	  to	  these	   for	  a	  more	   detailed	  consideration	  of	  the	   functional	   aspects	  of	  RNAi;	  we	  will	   focus	  here	  on	  the	  structural	   details	   and	  mecha-­‐nistic	  implications	  of	  the	  tethering	  of	  5´	  and	  3´	  ends	  of	  RNA	  (and	  DNA)	   that	   have	   emerged	   from	   structural	   studies	   of	   Argonaute-­‐nucleic	  acid	  complexes.	  Despite	  the	  diversity	  of	  interference	  mechanisms,	  silencing	   is	  mediated	  by	  a	   common	  structural	   unit	  formed	  by	  loading	  an	  Ar-­‐gonaute	  protein	  with	  a	  short	  RNA	  co-­‐factor	  of	  ~20-­‐30	  nucleotides	  in	   length	   to	  form	   the	   functional	   core	   of	  a	   protein-­‐RNA	   complex	  known	  as	  an	  RNA-­‐induced	  silencing	  complex	  (RISC).	  The	  inserted	  RNA	  guide	   strand	  is	   tethered	   to	  Ago	  at	   its	   5´	  and	   3´	   extremities	  and	   determines,	   via	   base-­‐pairing	   interactions,	   the	   speci^icity	   of	  RISC	  for	  RNA	  targets	  in	  the	  cell.	  The	   slicing	   and	  translation	  repression	  modes	  of	  RNAi,	  which	  have	  received	  the	  most	  attention	  to	  date,	  have	  similar	  pathways	  of	  RISC	   formation	   [3,	   85].	   This	   involves	   the	   initial	   loading	   of	   Ago	  with	  a	  small	  RNA	  duplex	  that	  is	  pre-­‐cut	  by	  Dicer,	  an	  RNase	  III-­‐type	  endonuclease	   that	   is	  speci^ic	   for	  dsRNA	  and	  uses	  speci^ic	  3´	  end	  recognition	   to	   generate	   duplexes	  of	  the	   appropriate	   length.	  The	  small	   RNA	   duplexes	   produced	   by	   Dicer	   have	   a	   characteristic	  monophosphate	  at	   the	  5´	  end	  and	  a	  dinucleotide	  overhang	   at	  the	  3´	  end,	  features	  that	  are	  speci^ically	  recognised	  by	  Ago.	  After	  load-­‐ing	   onto	   Ago	  one	   strand	  of	   the	   duplex	   is	   retained	   as	   the	   guide	  while	   the	   complementary	   passenger	   strand	   is	   cleaved	   and/or	  ejected.	  Although	  there	  are	  notable	  exceptions	  to	  the	  general	  rule,	  the	  particular	   mode	   of	   silencing	   enforced	  by	  RISC	   depends	   on	   the	  extent	  of	  base-­‐paring	  with	  the	  RNA	  target.	  Incorporation	  of	  short	  interfering	  RNAs	  (siRNA)	  normally	  leads	  to	  cleavage	   or	  slicing	  of	  the	   target	   RNA	   because	   extensive	   complementary	   base-­‐pairing	  activates	  the	  RNase	  activity	  of	  the	  Ago	  subunit.	   In	  contrast,	  when	  a	  microRNA	   (miRNA)	   guide	   strand	  within	  Ago	  recognises	  target	  sequences	  in	  mRNA	  3´-­‐untranslated	  regions,	  the	   interaction	  usu-­‐ally	   involves	   mis-­‐matches	  and	   results	   in	   imperfect	   base-­‐pairing.	  This	  prevents	  cleavage	  of	  the	  mRNA,	  even	  if	  the	  Ago	  protein	  has	  a	  functional	   active	   site,	   but	   leads	   to	   translational	   repression,	   by	  mechanisms	  that	  are	  still	  unclear	  [3,	  7].	  Argonaute	   proteins	   are	   also	  found	   in	   archaea	   and	   bacteria,	  although	   their	   roles	   in	   these	   domains	  of	   life	   have	   not	   yet	   been	  clari^ied:	   small	   RNAs	   have	   so	   far	   only	  been	  found	   in	   eukaryotes	  [84].	   Nevertheless,	   archaeal	   and	   bacterial	   Argonautes	  have	   sig-­‐ni^icant	   sequence	   homology	   with	   their	   eukaryotic	   counterparts	  and	  have	  been	  very	  useful	  for	  investigating	   the	  structures	  of	  Ago	  proteins	   [88-­‐93],	  particularly	  since	   it	   has	  proved	  dif^icult	  to	  pro-­‐duce	   samples	  of	  eukaryotic	  Agos	  that	   are	   suitable	   for	  structural	  analysis.	  The	  use	  of	  archaeal	  and	  bacterial	   Ago	  proteins	   in	   struc-­‐tural	   studies	   adds	   a	   potentially	   complicating	   factor	   in	   terms	  of	  
understanding	  eukaryotic	  RNAi,	  since	  these	  proteins	  appear	  to	  use	  DNA	  guide	  strands	  to	  target	  RNA	  for	  cleavage.	  Argonaute	   proteins	   (~100	   kDa)	   have	   four	   domains	   that	   fold	  into	   a	   ^lexible	   bi-­‐lobed	  structure	   that	   forms	   an	   extended	  binding	  platform	   for	   the	   guide	   strand	   RNA	   [89,	   92,	  93]	   (Fig.	  3a).	   The	   N-­‐terminal	   and	  PAZ	  domains	  form	   one	   lobe,	  while	  the	  MID	  and	  PIWI	  form	   the	   other.	   Initial	   structural	   work	   on	   domain	   fragments	   re-­‐vealed	  that	  the	  3´	  end	  of	  the	  guide	  strand	  is	  bound	  by	  the	  PAZ	  do-­‐main	  [94,	  95];	  the	  5´	  end	  is	  anchored	  by	  the	  MID	  domain	  within	  the	  MID/PIWI	   lobe	   at	   the	   other	   end	  of	   the	   binding	  platform	   [88,	  91].	  More	  recent	  work	  has	  begun	  to	  elucidate	  how	  an	  intact	  Ago	  protein	  ^ixes	  the	  guide	   strand	   in	   place	   so	   that	   it	   is	  poised	  to	  recognise	   its	  RNA	  target	  [89,	  90]	  (Fig.	  3a).
4.1.	  	  3´	  end	  recognition	  by	  PAZ	  domains.The	   structures	   of	  Ago	   PAZ	   domains	  have	   been	   solved	   for	  pro-­‐teins	   taken	   from	   all	   3	   domains	   of	   life	   in	   the	   free	   state	   and	   com-­‐plexed	  with	  a	   variety 	  of	  nucleic	  acid	  ligands:	   ssRNA	  [94],	  a	   duplex	  siRNA	  mimic	   [95]	  and—most	  recently—a	   DNA	  guide	  strand	  (with	  and	  without	   an	  RNA	  target	  present)	   [89,	  90].	  These	   structures	  re-­‐veal	   the	   general	   features	   of	   a	   conserved	  mode	  of	  3´	   end	  binding	  despite	  small	  structural	  variations	  between	  PAZ	  domains.	  The	   PAZ	   domain	   is	   composed	   of	   a	   compact	   oligonucleotide-­‐binding	   (OB)	   fold	   elaborated	   by	   an	   inserted	   mini-­‐domain	   that	  adopts	  a	  ββα	  [96,	  97]	  or	  αα	  topology	  [92,	  93].	  Initial	  solution	  and	  crystal	   structures	  of	  RNA	   complexes	  with	   PAZ	  domain	   fragments	  from	   two	  metazoan	   species	   revealed	   that	   the	   two	  nucleotides	  at	  the	  3´	  end	  insert	  into	  a	  pre-­‐formed	  cleft	  between	  the	  two	  domains,	  creating	   a	   distinctive	  mode	   of	  oligonucleotide	   binding	   that	   is	  not	  observed	  in	  other	  OB	  proteins	  [94,	  95]	  (see	  Fig	  2	  in	  [5]).	  The	   solution	  structure	   of	  the	  PAZ	  domain	  from	  Drosophila	  me-­
lanogaster	  Ago2	  (DmAgo2)	  complexed	  with	  a	  short	  single	  stranded	  RNA	  oligomer	  (5´-­‐CUCAC-­‐3´)	   resolved	  only	  the	  two	  terminal	  bases;	  the	   rest	  of	   the	  RNA	  was	  disordered,	  apparently	  not	   contacting	   the	  protein	   [94].	   Intriguingly	  the	   co-­‐crystallisation	  of	  the	   PAZ	  domain	  from	  human	  Ago1	  (HsAgo1)	  complexed	  with	  a	  9	  nt	  ssRNA	  inadver-­‐tently	  generated	  a	  short	  siRNA-­‐like	  duplex	  RNA	  with	  the	  character-­‐istic	   two-­‐base	   3´-­‐overhang	   [95].	   This	   interesting	   structure	   may	  represent	  a	   loading	  stage	  of	  RISC	  formation,	  prior	  to	  removal	  of	  the	  passenger	  strand.Comparison	  of	  the	  PAZ-­‐RNA	  complexes	  from	  HsAgo1	  and	  DmA-­‐go2	  shows	  that	  the	  ribose	  phosphate	  backbone	  of	  the	  terminal	  pair	  of	  nucleotides	   is	   inserted	   into	   the	   inter-­‐domain	   cleft	  and	   makes	  extensive	   interactions	  with	   the	   protein	   that	   are	   focused	   particu-­‐larly	  on	  the	   terminal	  nucleotide	  and	  the	   backbone	  connecting	  it	  to	  the	   penultimate	  base.	   The	   ribose	  of	  the	   terminal	   nucleotide	  occu-­‐pies	  the	  deepest	  part	  of	  the	   pocket.	   In	   the	  PAZ	  domain	   from	  HsA-­‐go1	  the	  2´	  and	  3´-­‐OH	  groups	  make	  hydrogen	  bonds	  with	  the	  amide	  and	   carbonyl	   groups	  of	  Tyr	   336	   respectively	  [95]	   (Fig.	   3b).	   The	  solution	  structure	  of	  the	  PAZ-­‐RNA	  complex	  from	  DmAgo2	  suggests	  that	  a	  similar	  pair	  of	  H-­‐bonds	  is	  made	  with	  the	  amide	  and	  carbonyl	  groups	  of	   the	   spatially	  equivalent	  residue,	  L110,	  although	   the	   ori-­‐entation	  of	  the	  ribose	  moiety	  is	   slightly 	  variable	   among	  members	  of	  the	   ensemble	  of	  structures	   [94].	  This	   interaction	  contrasts	  with	  3´	   recognition	   by	  La	   and	   NSP3,	   where	   charged	   side	   chains	   make	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Fig.	   3:	   Structures	   of	  RNAi	  effectors	   and	   repressors.	   (a)	  Structure	   of	  TtAgo	   complexed	   with	   a	   DNA	   guide	   strand	   (dark-­‐yellow)	  and	   RNA	   target	   strand	  (dark-­‐grey)	  [89].	  The	  domains	  of	  the	  Ago	  protein	  are	   colour	  differently	  and	   labelled.	  The	   disordered	  segment	   of	  the	   guide	   strand	  is	  indicated	  by	  a	  yellow	  dotted	   line.	   (b)	  Close-­‐up	  view	  of	   the	   binding	   of	  the	  3 	´  end	  of	  an	  RNA	   guide	   strand	   to	  HsAgo1	  [95].	  Selected	  side	   chains	  are	   shown	  as	  sticks	   and	  waters	  molecules	  as	   small	  spheres.	   (c)	  Close-­‐up	  view	  of	  the	   binding	   of	  the	   5 	´   end	  of	  an	  RNA	   guide	   strand	  to	  AfPiwi	  [91].	  The	  divalent	  metal	  cation	  that	  is	  coor-­‐dinated	  by	  the	  carboxy-­‐terminus	  of	   the	   protein	  (Leu	  427)	  and	  the	   phosphate	   groups	   of	   the	   ^irst	   and	   third	  nucleotides	  of	   the	   guide	   strand	  is	   shown	  as	  a	  purple	  sphere.	  Structures	  of	  (d)	  the	  CIRV	   p19	  homodimer	  [109]	   and	   (e)	  the	  TAV2b	  homodimer	  [108]	  in	  each	  case	   complexed	  with	  an	  siRNA	   duplex.	   The	  proteins	  are	   shown	   in	  a	   space-­‐^illing	   representation	  with	  the	  monomers	   coloured	   light-­‐blue	   and	   pink.	   Close-­‐up	   view	  of	  the	   recognition	  of	  the	  5´	  and	  3´	  ends	  of	   the	   siRNA	   duplex	   by	   (f)	  CIRV	   p19	   and	   (g)	  TAV2b.	   For	   the	   TAV2b	   structure	   the	   disordered	  3´	  overhang	   is	   depicted	   as	  an	   orange	   dotted	   line	   in	  panels	  e	  and	  g.
hydrogen	   bonds	  to	  the	   ribose	  hydroxyls	   [74,	  82]	   (Fig.	  2b,d).	  The	  non-­‐bridging	   oxygens	   of	   the	   phosphodiester	  backbone	   between	  the	   terminal	   pair	   of	   nucleotides	   make	   a	   further	   four	   hydrogen	  bonds	  with	  adjacent	  side	   chains	   in	  HsAgo1	   	   (Fig.	  3b).	  A	  similar	  array	   of	   side	   chains	   appears	   able	   to	   coordinate	   the	   bridging	  phosphate	   in	   DmAgo	   [94].	   The	   terminal	   ribose	   and	   base	   are	  packed	   snugly	  into	  one	   end	  of	  the	   pocket	  making	  van	  der	  Waals	  and	  hydrophobic	  contacts	  with	  the	  protein	  (a	  close-­‐packed	  mode	  of	  binding	   similar	   to	  that	   observed	  in	   rotavirus	  NSP3	   [82]	   –	   see	  above).	  The	   terminal	   base	  packs	  against	  the	  aromatic	   side	   chain	  of	   a	   conserved	  Phe	   in	   both	   structures	   (Phe	   292	   in	   Fig.	   3b),	   al-­‐though	  this	   is	  not	  a	   normal	  stacking	   interaction	  since	   the	   benzyl	  ring	   is	  oblique	  to	  the	  plane	  of	  the	   base.	  The	  two	  terminal	  nucleo-­‐tides	  of	  the	   guide	  strand	  are,	  however,	   stacked	  plane	   parallel	   on	  one	  another	  in	  such	  a	  way	  that	  their	  base-­‐pairing	   edges	  face	  out-­‐ward,	  thus	  avoiding	  any	  base-­‐speci^ic	  contacts	  with	  the	  protein,	  in	  keeping	   with	   the	   non-­‐sequence-­‐speci^ic	   nature	   of	   the	   PAZ-­‐RNA	  interaction	  (Fig.	  3b).	  More	   recent	   work	  has	   revealed	   that	   the	   3´	   end	   of	   the	   DNA	  guide	   strand	   in	   Thermus	   thermophilus	   Ago	   (TtAgo)	   binds	   to	   the	  PAZ	   domain	   in	   a	   manner	   that	   closely	   mimics	   RNA	   binding	   to	  eukaryotic	  PAZ	  domains	  [89,	  90].	  Strikingly,	   although	   the	   secon-­‐dary	   structure	   of	   the	   binding	   pocket	   is	   preserved,	   the	   detailed	  architecture	   is	  quite	  distinct	  and	  appears	  to	  re^lect	  the	  preference	  of	  the	  bacterial	   protein	   for	  DNA.	   In	   the	   PAZ	  domain	   from	   TtAgo	  the	   peptide	   backbone	   that	  runs	  underneath	   the	   ribose	   of	  the	  3´-­‐terminal	   nucleotide	   of	   the	   guide	   strand	   incorporates	   a	   proline	  residue	  (Pro	  225)	  that	  distorts	  the	  main	  chain	  from	  the	  conforma-­‐tion	  needed	  to	  make	  a	  pair	  of	  hydrogen	  bonds	  to	  the	  2´	  and	  3´-­‐OH	  groups	  of	  the	  terminal	   RNA	  base	   in	  eukaryotic	  PAZ	  domains	  [94,	  95].	  Instead	  recognition	  of	  the	   3´-­‐OH	  of	  the	  terminal	  DNA	  base	   is	  via	  hydrogen	  bonds	  to	  the	  side	  chain	  of	  His	  227	  and	  the	   carbonyl	  oxygen	  of	  Pro	  225	  [89,	  90].	  The	  dimensions	  of	  the	  pocket	  appear	  to	  leave	  no	  room	   for	  the	   2´-­‐OH	  that	  would	  be	  present	   in	   an	  RNA	  ligand.There	  are	  other	  interesting	   structural	  differences	  between	  the	  prokaryotic	   and	   eukaryotic	   PAZ	   domains	   that	   underscore	   how	  similar	  modes	   of	  binding	   can	   be	   achieved	   in	   different	  ways.	   Al-­‐though	   the	   non-­‐bridging	   oxygens	  of	  the	   terminal	   phosphate	   are	  also	   bound	   by	   hydrogen	   bonds	   to	   four	   side	   chains	   from	   TtAgo	  PAZ,	  only	  one	  of	  these	  (Tyr	  226)	  aligns	  with	  an	  equivalent	  residue	  in	  HsAgo1	  (Tyr	  309	   -­‐	  Fig.	  3b)	  [89,	  90].	  Moreover,	  there	  is	  no	  aro-­‐matic	  side	  chain	  to	  pack	  against	  the	  terminal	  base,	  closing	  off	  one	  end	  of	  the	  binding	  pocket;	   instead,	  this	  function	  is	  ful^illed	  by	  the	  hydrophobic	  side	  chains	  of	  Leu	  217	  and	  Pro	  218	  in	  the	  prokary-­‐otic	  PAZ.Although	   there	   is	   clearly	   a	   common	  mode	   of	   binding	   of	   the	  terminal	   dinucleotides	  of	  RNA	  and	  DNA	  guide	  strands	  to	  different	  PAZ	  domains,	  the	  path	  of	  the	   oligonucleotide	   upstream	  of	  the	  3´-­‐dinucleotide	  exhibits	  considerable	   variation	   in	   the	   known	  struc-­‐tures.	  In	  part	  this	  may	  arise	  from	  species	  differences	  or	  variations	  in	  the	  particular	  RNA	  and	  DNA	  ligands	  used	  in	  the	  structural	  stud-­‐ies	  reported	  to	  date,	   but	   it	  nevertheless	  seems	  likely	  that	  this	   is	  mostly	   due	   to	  the	  mobility	  of	  this	  portion	  of	  the	   tethered	   guide	  strand.	   Strong	   support	   for	   this	   notion	   comes	   from	   structural	  analysis	  of	  TtAgo	  bound	  to	  DNA	  in	  three	  different	  liganded	  states.	  In	  the	  binary	  TtAgo-­‐DNA	  complexes	  using	  truncated	  or	  full-­‐length	  
guide	   strands	   [90]	   and	   a	   ternary	   TtAgo	   -­‐guide	   DNA-­‐target	   RNA	  complex	   [89],	   the	   terminal	   two	  nucleotides	  are	   held	   in	   the	   same	  stacked	  conformation	  but	  the	  structures	   show	  clear	  divergence	   in	  the	  paths	  of	  the	  upstream	  sequences	  (see	  Fig.	  3b	  in	  [90]).	  Although	  the	  phosphate	  backbone	  of	  the	  guide	   strand	  can	  interact	  with	  resi-­‐dues	   lining	   the	   basic	   channel	   proceeding	   from	   the	   PAZ	   domain	  through	  to	  the	   MID/PIWI	  lobe	   that	  binds	   the	   5´ 	  end,	  there	   is	   evi-­‐dently	  a	   signi^icant	   degree	   of	  residual	   mobility,	  which	  may	  be	   im-­‐portant	  for	  target	  recognition	  (see	  below).	  The	   mode	   of	  recognition	  of	  a	   dinucleotide	  3´	  end	  overhang	   by	  PAZ	   domains	   that	   has	   emerged	   from	   these	   structural	   studies	   is	  consistent	   with	   binding	   studies.	   The	   snugness	   of	   ^it	   of	   the	   3´-­‐terminus	   in	   the	   binding	   pocket	   is	   con^irmed	   by	   the	   deleterious	  effect	  of	  covalent	  modi^ications	   of	  the	  2´	  and	  3´	  hydroxyls	  of	  RNA	  ligands	   [95].	   Moreover,	   it	   is	   clear	   that	   for	   double-­‐stranded	   RNA	  ligands	  a	  2-­‐nucleotide	   3´-­‐overhang	  provides	  for	  optimum	  binding	  af^inity	  [95-­‐97],	  a	   ^inding	  that	  is	  consistent	  with	  a	  possible	  role	  for	  PAZ	   in	  aiding	   the	   initial	   loading	   of	  dsRNA	  onto	  Ago	  during	   RISC	  assembly.	  Interestingly,	  Patel	   and	  colleagues,	  using	   surface	  plasmon	  reso-­‐nance	   to	   measure	   PAZ-­‐RNA	  interactions,	   found	   that	   extension	   of	  the	   3´-­‐overhang	   greatly	  reduced	   binding:	  a	   10	  nt	  overhang	   bound	  50-­‐fold	  less	  well	  than	  the	  optimal	  2	  nt	  overhang	  [95].	  Although	  this	  might	   be	   taken	   to	   suggest	   that	   RNA	  ligands	   with	   a	   more	   single-­‐stranded	  character	  may	  bind	   less	  well	   to	  the	   protein,	  the	  ^inding	   is	  not	  consistent	  with	  earlier	  measurements,	  made	  using	  competition	  cross-­‐linking	   assays,	   which	   showed	   that	   PAZ	   bound	   single-­‐stranded	  RNA	  and	  siRNA-­‐like	  duplexes	  with	  equal	  af^inity	  [96,	  97].	  The	   reason	   for	   this	   apparent	   discrepancy	   is	   not	   yet	   clear	   but	   is	  worthy	  of	  further	   investigation	  since	  differentiation	  between	  dou-­‐ble	   and	  single-­‐stranded	  ligands	  may	  play	  a	   role	  in	  the	  formation	  of	  active	  RISC.	  However,	   it	  may	  be	  more	  rewarding	  —	  though	  clearly	  more	  dif^icult	  —	  to	  probe	   the	   contribution	  of	  PAZ	  to	  RNA	  binding	  within	  the	  context	  of	  intact	  Ago	  proteins.	  
4.2.	  	  5´	  end	  recognition	  by	  MID/PIWI.Anchoring	  and	  presentation	  of	  the	  5´	  end	  of	  guide	  strand	  by	  Ago	  proteins	   are	   critical	   for	   two	   reasons.	   Firstly,	   cleavage	   of	   target	  RNAs	  during	  slicing	  is	  measured	  speci^ically	  from	  the	  5´	  end	  of	  the	  guide	   strand	   and	   occurs	   between	   the	   nucleotides	   that	   are	   base-­‐paired	  to	  nucleotides	  10	  and	  11	  of	  the	   guide	   [3].	  Secondly,	  nucleo-­‐tides	  2-­‐7	  of	  the	  guide	  strand	  (the	   seed	  sequence)	   have	  been	  found	  to	  be	   the	  most	  important	  determinants	  of	  speci^ic	  target	  recogni-­‐tion,	  for	  both	  slicing	  and	  translation	  repression	  modes	  of	  RNAi	  [98,	  99].	  As	  with	  3´	   end	   recognition,	   structural	   analyses	   have	   detected	  common	   modes	   of	   binding	   of	   the	   5´	   end	   of	   both	   RNA	   and	   DNA	  guide	   strands	  by 	  the	  MID/PIWI	  lobe	   of	  Ago	  and	  homologous	  Piwi	  proteins.	  The	  structural	  work	  has	  so	  far	  been	  con^ined	  to	  archaeal	  and	  bacterial	  proteins	  but	  sequence	  homology	  and	  structure-­‐based	  mutagenesis	   strongly	   suggest	   that	   many	   of	   the	   key	   features	   of	  5´	  end	  recognition	  will	  also	  be	  found	  in	  eukaryotic	  orthologues.	  The	  crystal	   structures	  of	  archaeal	  Ago	  proteins	  from	  Pyrococcus	  
furiosus	   (PfAgo)	   and	   Archaeoglobus	   fulgidus	   (AfPiwi)	   established	  that	   the	  MID	  domain	   resembles	   the	   sugar-­‐binding	   domain	   of	   the	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lac	   repressor,	   whereas	   the	   PIWI	   domain	   has	   a	   similar	   fold	   to	  RNase	  H	  and	  contains	  the	  catalytic	  centre	  of	  the	  protein	  [92,	  100].	  Shortly	  thereafter,	  co-­‐crystal	   structures	  of	  AfPiwi 	  with	  two	  differ-­‐ent	  siRNA-­‐like	  duplexes	  [88,	  91]	  revealed	  the	  key	  features	  of	  how	  the	  5´	  end	  of	  the	  guide	  strand	  is	  anchored	  to	  the	  protein	  and	  may	  interact	   with	   passenger	  or	   guide	   strands.	   Although	   AfPiwi 	   is	   a	  small	  Ago	  protein	  lacking	  the	  N-­‐terminal	  and	  PAZ	  domains	  (which	  probably	  made	   it	  more	  amenable	  to	  co-­‐crystallisation	  studies),	  its	  observed	   mode	   of	   RNA	   binding	   has	   been	   generalised	   to	   DNA	  ligands	  and	  to	  full-­‐sized	  Ago	  proteins	  [89,	  90,	  101].	  At	   the	  5´	  end	  of	  the	   guide	  strand,	  interaction	  with	   the	   AfPiwi	  Ago	  protein	  forces	  the	   ^irst	  nucleotide	   to	  ^lip	   out	  of	  its	  base-­‐pair	  interaction	   with	   the	   complementary	   strand	   into	   a	   highly-­‐conserved	   pocket	   that	   is	   formed	   almost	   exclusively	   from	   MID	  domain	   residues	   but	   is	   positioned	   close	   to	   the	   interface	   of	   the	  MID	  and	  PIWI	  domains	  [88,	  91]	  (Fig.	  3c).	  This	  allows	  the	  terminal	  monophosphate	   to	  bind	  at	   the	   deepest	   part	   of	   the	   cleft	  where	   it	  makes	  numerous	  hydrogen	  bond	  or	  salt-­‐bridge	   interactions	  with	  four	  amino-­‐acid	  side	   chains,	  the	  amide	  nitrogen	  of	  Phe	  138	  and	  a	  divalent	  metal	   cation	   that	   is	  co-­‐ordinated	  by	  Gln	  159	  and	  —	  un-­‐usually	   —	   the	   C-­‐terminal	   carboxylate	   moiety	   of	   the	   protein	  (Leu	  427).	  The	  bound	  cation	  also	  interacts	  with	  the	   phosphate	   of	  the	   third	  nucleotide	  of	  the	   guide	   strand	   so	   that	  the	  backbone	  of	  the	   ^irst	   three	   residues	   is	   pinched	   into	   a	   tight	   U-­‐bend	  (Fig.	   3c).	  This	  mode	  of	  binding	   is	   likely	  to	  be	   replicated	  in	   eukaryotic	  Ago	  proteins	  since	   the	  side-­‐chain	   ligands	  for	  the	  monophosphate	   are	  all	  strongly 	  conserved,	  a	  contention	  supported	  by	  the	  ^inding	   that	  mutation	  of	  the	  equivalent	  residues	  in	  HsAgo2	  impaired	  its	  slicing	  activity,	   presumably	   due	   to	   mis-­‐placement	   of	   the	   5´	   end	   of	   the	  guide	  strand	  [88].	  The	   pocket	   that	  accommodates	   the	   5´-­‐monophosphate	   is	   less	  snug	  than	  the	   cleft	  in	  the	  PAZ	  domain	  that	  binds	  the	  3´	  end	  of	  the	  guide	  strand	  and	  there	  is	  room	  for	  several	  bound	  water	  molecules	  in	  the	   vicinity	  of	  the	  5´-­‐terminus	  (Fig.	  3c).	  This	  suggests	   that	   the	  pocket	   may	   be	   able	   to	   accommodate	   secondary	   siRNA	   guide	  strands	   that	   are	   generated	   by	   RNA-­‐dependent	   polymerases	   to	  amplify 	  the	   silencing	   signal	   in	   some	   siRNA	  pathways	  and	   there-­‐fore	  have	  di-­‐	  and	  triphosphate	  groups	  at	  their	  5´	  ends	  [84,	  86].The	   base	   of	   the	   ^irst	   nucleotide	   is	   accommodated	   within	   a	  binding	   slot	  adjacent	   to	  the	   phosphate	   pocket	  where	   it	   is	  stabi-­‐lised	  by	  stacking	  underneath	  Tyr	  123	  (Fig.	  3c).	  A	  second	  tyrosine	  (Tyr	   118)	   sits	  below	   the	   base,	   though	   its	  position	   is	  somewhat	  variable	   between	   the	   three	   co-­‐crystal	   structures	   that	   have	   been	  determined.	  Only	  in	  the	  structure	  with	  a	  DNA	  guide	  strand	  does	  Tyr	  118	  form	   the	   bottom	   layer	  of	  a	   sandwich	  that	   resembles	  the	  paired	   arrangement	   of	   aromatic	   side	   chains	   that	   is	   common	   in	  cap-­‐binding	   proteins	  [101]	   .	   	  The	   edge	   of	  the	   base	  (U	  or	  A	  in	  the	  two	  structures	  with	  RNA	  [88,	  91]	  and	  T	  in	  a	  structure	  with	  a	  DNA	  duplex	   [101])	   makes	  one	   or	   two	  hydrogen	  bonds	  on	   one	   side	  of	  the	   binding	   cleft	   but	   there	   appears	   to	   be	   no	   selectivity	   for	   the	  identity	   of	   the	   5´-­‐terminal	   base	   in	   AfPiwi.	   In	   contrast,	   some	  eukaryotic	   Ago	   proteins	   have	   a	   preference	   for	   particular	   5´-­‐nucleotides,	   presumably	   due	   to	   modi^ications	   of	   the	   binding	  pocket	  that	  confer	  base-­‐speci^icity	  [3].	  The	   interactions	  of	  the	  5´	  terminal	  base	  with	  the	  MID	  domain	  inhibit	   it	   from	  base-­‐pairing	   with	   target	   RNA	  and	   provide	   an	  ex-­‐
planation	  for	   the	   observation	   that	  a	   mis-­‐match	   at	   this	   position	   is	  not	  important	  for	  target	  recognition	  [3,	  84].	  Intriguingly,	  it	  has	  also	  been	   found	   that	   this	   mismatch	   can,	   in	   some	   circumstances,	   en-­‐hance	   slicing	  activity 	  [99].	  It	  may	  be	  that	  a	   target	  capable	  of	  base-­‐pairing	   with	   the	   guide	   strand	  at	   this	  ^irst	   position	  destabilises	   its	  interaction	   with	   the	   protein,	  weakening	   the	   5´-­‐anchoring	   by	  Ago	  and	   perhaps	  leading	   to	  mis-­‐positioning	   of	  the	  scissile	  bond	  of	   the	  target	  with	  respect	  to	  the	  active	  site.	  A	  small	  dislocation	  of	  the	  sub-­‐strate	  would	  be	  suf^icient	  to	  signi^icantly	  impair	  slicing	  activity.	  Immediately	   downstream	   of	   the	   5´-­‐terminal	   nucleotide,	   the	  backbone	   makes	   a	   number	   of	   direct	   and	   water-­‐mediated	  hydrogen-­‐bonds	  with	  the	  protein,	   so	   that	   the	  bases	  in	   the	   5´ 	  sec-­‐tion	   of	   the	   guide	   are	   exposed	   and	   available	   for	  base-­‐pairing	   with	  the	   target.	  However	  beyond	  the	   third	  nucleotide	   the	   paths	   of	   the	  different	   RNA	   and	   DNA	   guide	   strands	   in	   the	   reported	  structures	  begin	   to	  diverge	   [88,	  89,	  101].	  Moreover,	  the	   duplexes	  are	   disor-­‐dered	   at	   their	   3´	   ends	  such	  that	   only	  four	  or	  ^ive	   base-­‐pairs	   are	  observable,	   fewer	  than	  half	  the	   number	  expected	  from	   the	   dsRNA	  and	   dsDNA	  ligands	  used	  in	   co-­‐crystallisation	  [88,	  89,	  101].	  These	  observations	  are	   rather	  surprising	  given	  that	  fully	  complementary	  oligonucleotides	  were	  used	  to	  prepare	   the	  duplexes	  in	  each	  case.	  It	  might	  have	  been	  thought	  that	  the	  disorder	  in	  the	  duplexes	  was	  due	  to	  the	  absence	  of	  a	  PAZ	  domain	  in	  AfPiwi	  to	  tether	  the	  3´	  end	  of	  the	  guide.	   However,	   the	   structure	   of	  TtAgo	   in	  a	   complex	  with	   a	   DNA	  guide	   and	  an	   RNA	  target	  strand	  shows	   that,	  despite	  anchoring	   of	  the	   3´	   end	  of	   the	   guide	   in	   its	   PAZ	   domain,	  the	  3´	  segment	   of	   the	  duplex	   is	  also	  disordered	  [89]	   (Fig.	  3a).	   The	   evident	   ^lexibility	  of	  this	  portion	  of	  the	  guide-­‐target	  duplex,	  in	  contrast	   to	  the	  clear	  sta-­‐bilisation	  of	  the	  5´	  end	  of	  the	  guide	   strand	  may	  therefore	  be	  a	  gen-­‐eral	   feature	  and	   is	  consistent	  with	   some	   of	   the	   known	  features	  of	  target	  selection.It	  is	  well	   established	  that	  base-­‐pairing	  between	  the	   target	  RNA	  and	  nucleotides	  2-­‐7	  at	  the	  5´	  end	  of	  the	  guide	  strand	  (the	  so-­‐called	  seed	  region)	   are	  major	   determinants	   of	   RISC	   speci^icity	   [98,	   99].	  Although	  base-­‐pairing	  of	  the	  target	  to	  the	  3´	  end	  of	  the	  guide	  is	  less	  important	  for	  speci^icity	  in	  both	  slicing	  and	  translation	  repression	  modes	  of	  silencing	  [98,	  99],	  it	  can	  still	   contribute	  to	  ef^icacy.	  A	  case	  in	  point	   is	  the	   observation	  that	   base-­‐mismatches	  in	   the	   3´	   end	  of	  the	   guide	   reduce	   the	  catalytic	  ef^iciency	  of	  slicing	   by	  DmAgo	  [99].	  The	   current	  hypothesis	  of	   target	  recognition	  is	  that	   initial	   contact	  may	  be	  established	  by 	  base-­‐pairing	  of	  the	  target	  to	  the	  seed	  region,	  followed	  by	  propagation	  of	  base-­‐pairing	   towards	  the	  3´	  end	  of	  the	  guide	   strand	   [98,	  99].	  This	  mode	  of	  action	   is	   supported	  by	  recent	  binding	   analyses	   of	   target	   recognition	   by	  AfPiwi-­‐guide	   complexes	  which	  showed	  that	  stabilisation	  of	  the	  5´	  end	  of	  the	  guide	  strand	  by	  interaction	  with	  the	  protein	   enhances	   the	   binding	   energy	  derived	  from	   base-­‐pairing	   of	  the	   guide	   with	   the	   target	   by	  paying	   for	   the	  entropic	  cost	  of	  the	  interaction	  [101].	  It	   is	  still	  unclear	  why	  stable	  base-­‐pairing	   of	   the	   target	   to	   the	   3´	   segment	   of	   the	   guide	   strand	  downstream	  of	  the	   scissile	   bond	  was	  not	  observed	   for	  TtAgo	  [89].	  Conceivably	  the	  duplex	   is	  formed	  but,	  because	   there	  are	  no	  stabi-­‐lising	   interactions	  with	  the	  protein,	   it	   remains	   ^lexible	   and	   there-­‐fore	   invisible	   to	   crystallographic	   analysis.	   This	   order-­‐disorder	  transition	  along	   the	   length	   of	   the	   guide	   strand	  may	  be	   necessary	  for	  key	  functions	  of	  Ago:	   stabilisation	  of	  the	   5´	  end	  of	  the	  guide	  to	  allow	  accurate	  measurement	  of	  the	  position	  of	  cleavage	   of	  the	   tar-­‐get	  but	  loose	   attachment	  of	  the	   3´	  segment	   of	  the	  guide	  to	  permit	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accommodation	  of	  guide	   strands	  of	  variable	   lengths.	  The	  evident	  ^lexibility	  of	  Ago	  may	  also	  contribute	  to	  the	   ability	  of	  the	   protein	  to	  use	  guide	  strands	  of	  different	  sizes	  [89,	  90].Although	   the	   extreme	   3´	   end	   of	   the	   guide	   is	   observed	   to	  be	  bound	  to	  the	  PAZ	  domain	  in	  TtAgo	  in	  the	  absence	  and	  presence	  of	  a	  target	  RNA,	  it	  is	  still	  not	  clear	  if	  this	  end	  remains	  attached	  to	  the	  protein	   during	   ‘complete’	   target	   recognition.	   The	   formation	   of	  base-­‐pairs	  along	  the	  whole	   length	  of	  the	   target	  strand	  would	  gen-­‐erate	   two	  turns	  of	  A-­‐form	  double	  helix.	  Topologically,	  it	  is	  dif^icult	  to	  see	  how	  this	  can	  be	   achieved	  if	  the	  3´	  end	  of	  the	  guide	  remains	  tethered	  to	  the	  protein	  [3,	  85].	  A	  new	  and	  interesting	  dimension	  to	  the	  ability 	  of	  Ago	  proteins	  to	   recognise	   the	   ends	   of	   RNA	   molecules	   has	   emerged	   recently	  with	  reports	  that	  they	  may	  also	  be	  able	   to	  bind	  the	  5´	  m7G	  cap	  of	  mRNA	  targets	  that	  are	   the	   subject	  of	  RISC-­‐mediated	  translational	  repression	   [102,	   103].	   The	   working	   hypothesis	   is	   that	   miRNA-­‐loaded	   RISCs	   tethered	   to	  near-­‐complementary	   sequences	   in	   the	  3´-­‐UTRs	  of	  target	  mRNA	  may	  inhibit	  translation	  initiation	  by	  se-­‐questering	   the	   5´	   cap	   of	   the	   message	   from	   eIF4E.	   However,	   this	  model	  has	  been	  challenged	  in	  later	  work	  [104,	  105].	  In	  particular,	  an	  initial	   report	  [103]	  that	  the	  MID	  domain	  contains	  an	  eIF4E-­‐like	  motif	   complete	   with	   a	   conserved	   pair	   of	   aromatic	   residues	   to	  sandwich	  the	  m7G	  cap	  has	   proved	  —	   on	   the	   basis	   of	   a	   detailed	  sequence	   and	   structural	   comparison	  —	   to	   be	   unfounded	   [106].	  Further	  binding	   and	   structural	   analyses	   are	   needed	   to	   put	   the	  putative	  cap-­‐binding	  properties	  of	  Ago	  on	  a	  secure	  footing.
5.	  	  Binding	  of	  siRNAs	  by	  viral	  suppressor	  proteins.
	  Plants	   and	   invertebrates	  use	   RNAi	  as	   a	   defence	  mechanism	  against	  viral	   infection	   and,	  as	  a	   counter-­‐strategy,	  viruses	  express	  suppressor	  proteins	  to	  inhibit	   the	  RNAi	  response	  of	  the	  host	  cells	  [107].	   Although	   several	   different	   viral	   anti-­‐silencing	   strategies	  have	  been	  identi^ied,	  the	  best	  characterised	  suppressors	  are	  those	  that	   function	   by	  binding	   to	  siRNA	  duplexes,	  thus	   inhibiting	   RISC	  assembly.	  Structures	  have	  been	   reported	  for	  the	  Tomato	  aspermy	  
virus	  protein	  2b	  (TAV2b)	   [108]	  and	  two	  related	  p19	  proteins	  from	  the	   tombusvirus	   genus	   [109,	   110].	   These	   suppressors	   bind	   spe-­‐ci^ically	  to	  siRNA	  duplexes	  of	  de^ined	   length	  using	   a	   “molecular	  calliper”	  arrangement.The	   crystal	   structure	   of	   the	   p19	  suppressor	  bound	  to	  siRNA	  has	   been	   determined	   both	   for	  Tomato	   bushy	   stunt	   virus	   (TBSV)	  [110]	   and	   the	   closely	   related	   Carnation	   Italian	   ringspot	   virus	  (CIRV)	   [109]	   (Fig.	   3d).	  As	   expected,	  the	   two	  proteins,	  which	   are	  both	   homodimeric,	   have	   nearly	   identical	   structures	   and	   bind	  siRNA	  in	  the	  same	  manner.	  The	  dimer	  has	  a	  central	  8-­‐stranded	  β-­‐sheet	  that	  is	  formed	  by	  the	  association	  of	  the	   two	  C-­‐terminal	  do-­‐mains	   and	   capped	   at	   each	   end	   by	   the	   N-­‐terminal	   domains.	   P19	  binds	   the	  siRNA	  duplex	  symmetrically;	   the	   ends	  of	  the	   siRNA	  are	  bound	   to	   the	   N-­‐terminal	   domains	  while	   the	   body	  of	  the	   duplex	  lies	   across	   the	   β-­‐sheet	   surface,	   interacting	   directly	  or	   via	  water	  molecules	  with	   the	   phosphates	   of	   the	   backbone	   and	   the	   2´	   OH	  groups	  of	  the	  sugars.	  The	   19bp	   RNA	   in	   the	   complex	   adopts	   the	   standard	   A	   form	  conformation	  but	   the	   two	   unpaired	  bases	  at	   each	  of	  the	   3´	  ends	  are	  unstacked	  and	   twist	   away	  from	  the	  helix	   (Fig.	  3d).	  Two	  tryp-­‐
tophan	  residues	  in	  each	  monomer	  of	  the	  suppressor	  stack	  onto	  the	  exposed	  bases	   at	   the	   5´	  and	   3´	   ends	  of	   the	   double	   stranded	  RNA	  (Fig.	   3f).	   The	   highly	   conserved	  Trp	   42	   stacks	   against	   the	   5´	  base	  while	  Trp	  39	  stacks	  against	   the	   last	   paired	  3´	  base.	  The	   imino	  ni-­‐trogen	   of	   Trp	   42	   also	  makes	   a	   hydrogen	  bond	  with	   the	   5´	  phos-­‐phate	   in	   the	   CIRV	   p19	   structure	   (the	   RNA	  used	  to	  co-­‐crystallised	  TBSV	  p19	  was	  unphosphorylated	  [110]).	  The	  unpaired	  3´	  bases	  are	  disordered	  in	  the	  TBSV	  p19	  crystal	   structure	   and	  make	  only	  weak	  interactions	   with	   the	   protein	   in	   the	   CIRV	   structure.	   As	   expected	  from	   the	   sequence-­‐independent	  mode	   of	  binding,	   there	   are	   no	  di-­‐rect	  interactions	  of	  the	  protein	  with	  the	  RNA	  bases.Electrophoretic	  gel	  mobility	  shift	   assays	   showed	   that	  removal	  of	  the	   5´	  phosphate	  signi^icantly	  reduced	   the	   af^inity	  for	  CIRV	   p19	  for	   a	   21	   nt	   siRNA,	   consistent	   with	   its	   close	   interaction	  with	   the	  protein.	   Elimination	   of	  the	   unpaired	   3´	  nucleotides	   actually	  mar-­‐ginally	  increased	   the	   af^inity	  [109],	  a	   result	   that	  is	  in	  marked	  con-­‐trast	  to	  the	   effect	  that	   this	  change	   has	  on	   the	   binding	  of	  siRNA	  to	  PAZ	  [95,	  96].	  The	  difference	   is	  evidently	  due	  to	  the	  fact,	  unlike	  p19,	  PAZ	  accommodates	  the	  overhang	  in	  a	  speci^ic	  binding	  pocket.	  Although	  the	  p19	  suppressor	  binds	  most	  tightly	  to	  21-­‐nt	  siRNA	  as	  used	   in	  the	   crystal	   structures,	  it	  can	  also	  accommodate	   slightly	  longer	  siRNA	  duplexes	  albeit	  with	  reduced	  af^inity	  [109].	  This	  may	  be	  a	  necessary	  strategy	  for	  the	  virus	  as	  not	  all	  siRNAs	  are	  the	  same	  size.	   For	  example	   the	   different	   Dicer-­‐like	   proteins	   in	  Arabidopsis	  
thaliana	  produce	  siRNA	  duplexes	  with	  lengths	  ranging	   from	   21	  nt	  to	  24	  nt	  [111].	  The	  RNA	  interference	  suppressor	  Tomato	  aspermy	  virus	  protein	  2b	  is	  also	  dimeric	  and	   	  binds	  siRNA	  with	  a	   symmetric	  “molecular	  calliper”	   arrangement	   using	   tryptophan	  residues,	  but	   has	  a	   strik-­‐ingly	   different	   architecture	   from	   the	   p19	   suppressor	   [112]	   (Fig.	  3e).	  Each	   monomer	  is	  95	   amino	  acids	  long	   but	  so	  far	  it	   has	  only	  been	   possible	   to	   obtain	   crystals	   of	   the	   fragment	   1-­‐69	   bound	   to	  siRNA.	  These	  fold	  into	  a	   pair	  of	  hinged	  helices	  that	  insert	   into	  the	  major	  groove	  of	  the	  A-­‐form	   dsRNA.	  The	  dimer	  interface	   is	  surpris-­‐ingly	  small,	  comprising	  only	  a	  handful	  of	  residues	  at	  the	   beginning	  of	  the	  N-­‐terminal	  helix.Trp	  50	  in	  the	  C-­‐terminal	  helix	  of	  each	  monomer	  stacks	  onto	  the	  exposed	  5´	  base	  of	  the	  dsRNA	  (Fig.	  3g).	  This	  tryptophan	  is	  not	  con-­‐served	  in	  the	   homologous	  2b	  protein	  from	  Cucumber	  mosaic	  virus,	  which	  has	  an	  arginine	  residue	  at	  this	  position,	  a	  substitution	  that	  is	  also	  seen	  in	  the	  binding	  pocket	   for	  the	  5´	  base	   of	  the	  guide	  strand	  between	  different	  Ago	  proteins	  (see	   above).	  Unsurprisingly	  there-­‐fore,	  mutation	  of	  Trp	  50	  to	  Arg	  reduces	  the	  RNA	  binding	   af^inity	  of	  TAV2b	  only	  by	  a	   factor	  of	  two,	  though	  mutation	  to	  Ala	  knocks	  bind-­‐ing	   down	   ^ive-­‐fold.	   The	   5´	   phosphate	   forms	   a	   salt	   bridge	   with	  Lys	   39	   and	  also	   interacts	  with	  His	   51.	  The	   unpaired	  3´	  bases	   are	  disordered	  in	  the	  crystal	   structure	  suggesting	   that	  —	  as	  in	  p19	  —	  they	  do	  not	  form	  strong	  interactions	  with	  the	  suppressor	  molecule,	  but	   this	  observation	  awaits	   con^irmation	   since	   the	   last	  21	   amino	  acids	   of	   the	   monomer	  were	   not	   present	   in	   the	   protein	   used	   for	  crystallisation.	   It	   is	   perhaps	   notable	   that	   RNA	  binding	   measure-­‐ments	  made	  with	  the	  same	  protein	  fragment	  that	  was	  used	  to	  grow	  crystals	   yielded	   a	   KD	   of	   75	   nM	   for	   a	   21-­‐nt	   siRNA	   duplex	   [108],	  which	  indicates	  an	  af^inity	  that	   is	  about	  400	   times	   lower	  than	  p19	  [109].	  Given	   that	  TAV2b	  and	  p19	  have	   similar	  functions	  and	  bind-­‐ing	   targets	   within	   plant	   cells,	   one	   might	   have	   expected	   them	   to	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bind	   with	   similar	   af^inities.	   It	   is	   possible	   that	   the	   missing	   C-­‐terminal	   region	   of	  TAV2b	   accounts	   for	   the	   lower	   af^inity	   of	   the	  protein	  observed	  in	  these	  experiments.	  Surprisingly,	   the	   TAV2b	  fragment	   binds	  to	  a	  32	  nt	  siRNA	  du-­‐plex	  with	  a	  dissociation	  constant	  only	  a	   factor	  of	  two	  greater	  than	  that	   for	  21	  nt	  siRNA.	  This	  would	  suggest	  that	  most	  of	  the	   binding	  energy	  derives	   from	   the	   interaction	  of	  the	  protein	  α-­‐helices	  with	  the	  RNA	  major	  groove.	   It	  is	  not	   clear	  from	  the	  structure,	  particu-­‐larly	  since	   it	  is	  incomplete,	  whether	  TAV2b	  could	  bind	  both	  ends	  of	  such	  a	   long	   dsRNA	  target	  but	  perhaps	  binding	  of	   the	  dimer	   to	  one	  5´	  end	  and	  most	  of	  the	  body	  of	  the	  RNA	  duplex	  is	  suf^icient	  to	  confer	  speci^icity.
6.	  	  5´-­monophosphate	  recognition	  by	  RNaseEWhile	   the	   m7G	  cap	   added	  to	  the	   5´-­‐end	  of	  eukaryotic	  mRNAs	  serves	   to	   protect	   them	   from	   degradation	   pathways,	  prokaryotic	  mRNAs	  are	  uncapped	  [113].	  Nevertheless,	  in	  bacteria	  retention	  of	  the	  5´-­‐triphosphate	  moiety	  is	  suf^icient	  to	  inhibit	  mRNA	  turnover	  and	   diversion	   to	  degradation	  pathways	  is	  only	  initiated	   once	   the	  RNA	  pyrophosphohydrolase	  RppH	  converts	  the	  5´	  end	  to	  a	  mono-­‐
phosphate	   [114,	  115].	   Following	   this	  modi^ication	   the	   mRNA	  be-­‐comes	  a	  speci^ic	  substrate	  for	  the	  RNaseE	  endonuclease.Crystallographic	  analysis	  of	  RNaseE	  revealed	  that	  the	  enzyme	  is	  a	   homotetramer	   composed	   of	   multi-­‐domain	   subunits.	   The	   core	  catalytic	  units	  of	  the	  enzyme	  are	  composed	  a	  pair	  of	  dimers;	  within	  each	   dimer	   a	   sensor	   domain	   from	   one	   monomer	   binds	   the	   5´-­‐monophosphate	   of	  the	   RNA	  substrate,	   but	   cleavage	   is	   performed	  several	   nucleotides	   downstream	   by	   the	   active	   site	   of	   the	   other	  monomer	  (Fig.	  4a).	  In	  broad	   terms	  there	  are	   similarities	  with	  Ago	  in	  the	  way	  that	  binding	  of	  the	  5´-­‐end	  of	  the	   substrate	  is	  coordinated	  with	  endonu-­‐cleolytic	  cleavage	  downstream.	  However,	  there	  are	  two	  key	  differ-­‐ences:	  ^irstly,	  RNaseE	  is	  a	   non-­‐speci^ic	  endonuclease	  —	  there	   is	  no	  guide	   strand	  —	   and,	   secondly,	   it	   does	   not	  measure	   the	   distance	  between	   the	   5´-­‐end	   of	   the	   substrate	   and	   the	   cut	   site.	   Crystallo-­‐graphic	  analysis	  of	  RNaseE	   in	  complex	  with	   three	   RNA	  substrates	  of	   different	   sequences	   and	   lengths	   (10,	   13	   and	   15	   nucleotides)	  readily	   explains	   the	   structural	   basis	   of	   these	   distinguishing	   fea-­‐tures	  [6,	  116].	  The	  RNA	  substrate	   is	  bound	  with	  its	  5´-­‐monophosphate	   tucked	  into	  a	  pocket	  formed	  by	  the	  sensor	  domain	  (Fig.	  4b).	  This	  pocket	  is	  connected	  to	   the	   active	   site	  of	  a	   neighbouring	  monomer	  by	  a	  sur-­‐
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Fig.	   4:	   Structures	   of	   RNaseE	  complexed	  with	  mRNA	   substrates	   containing	   a	   5´-­‐monophosphate	   group.	   (a)	  Overview	   of	   a	   catalytic	   dimer,	   formed	   from	  two	  identical	  subunits.	  The	   dimeric	  two-­‐fold	  symmetry	  axis	   is	  perpendicular	   to	  the	   plane	   of	  the	   page.	   Subunit	  1	   is	  depicted	  in	  a	  yellow	  surface	   represen-­‐tation	  with	  the	   bound	   RNA	   shown	   as	   an	  orange	   ribbon.	  The	   left-­‐hand	  subunit	   (green)	  is	   drawn	  schematically	  with	   bound	  RNA	   represented	   by	   sticks	  coloured	  by	  atom	   type.	  The	  Mg2+	   ions	  associated	  with	  the	   two	  active	   sites	   of	  the	  dimer	  are	   shown	   as	  blue-­‐green	  spheres.	   (b)	  Close-­‐up	  of	   subunit	   1	  with	  the	   structures	   of	   two	   different	   bound	  RNAs	   superposed	  –	  5´-­‐ACAGUAUUUG	   (orange)	  and	   5´-­‐UUUACAGUAUUUG	   (blue).	   With	   reference	   to	   panel	  a,	   the	  view	   is	   tilted	   around	   the	   horizon	   axis	   by	  about	   20°.	   (c)	  Close-­‐up	  of	   the	   binding	   pocket	   for	   the	   5´-­‐monophosphate	   of	   5´-­‐UUUACAGUAUUUG	   shown	   in	  sticks	  coloured	  by	  atom-­‐type.	  Selected	  protein	  side	  chains	  are	  also	  shown	  as	  sticks.	  The	  orientation	  is	  similar	  to	  panel	  b.
face	   channel	   that	  binds	  the	  downstream	   portion	   of	  the	  RNA;	   the	  mode	  of	  binding	  allows	  some	  of	  the	  intervening	   sequence	  to	  loop	  out,	  away	  from	  the	  enzyme	  surface.	  	  Within	   the	   pocket	   that	  binds	  the	   5´	  end	  of	  the	   RNA	  there	   are	  no	  hydrogen	  bonds	   to	  the	   terminal	   base,	  although	   the	   side	  chain	  of	   Val	   128	   provide	   important	   non-­‐speci^ic	   contacts	   to	   the	   sub-­‐strate	   [116].	   Speci^ic	   recognition	   of	   the	   5´-­‐monophosphate	   is	  achieved	   through	   hydrogen	   bonds	   from	   Arg	   169	   and	   Thr	   170	  deep	  within	  the	  sensor	  pocket	  (Fig.	  4c).	  The	  side	   chain	  of	  Arg	  371	  may	  also	   contribute	   to	  binding	   though	   its	   position	   varies	  with	  different	  RNA	  substrates.	  Arg	  373	  appears	  to	  contribute	  to	  stabi-­‐lisation	  of	  the	  5´-­‐end	  since	   it	  can	  form	  salt	  bridges	  with	  the	  back-­‐bone	  phosphates	  with	  the	  nucleotides	  at	  the	  beginning	  and	  end	  of	  the	   portion	   of	  the	  RNA	  that	   is	   looped	  out	   (positions	  2	   and	  5	  for	  the	  RNA	  in	  Fig.	  4c).	  However,	  again,	  this	  interaction	  is	  not	  consis-­‐tently	  observed	  since	  in	  one	  complex	  (PDB	  2c4r)	  the	  side	  chain	  is	  disordered.	  Therefore	  the	  pocket	  that	  binds	  the	  5´	  end	  of	  the	  RNA	  appears	   to	   exhibit	   a	   certain	  degree	   of	   ^lexibility.	   In	   RNaseE	   this	  ^lexibility,	  along	  with	  the	  presence	  of	  a	  cavity	  beneath	  the	  position	  of	   the	   bound	  5´-­‐terminus	  may	  account	   for	   the	   observation	   that	  RNasE	   binds	   RNAs	   with	   5´-­‐monophosphate	   or	   5´-­‐triphosphate	  with	  similar	  af^inities	   [117].	  The	   enhanced	   rates	  of	   cleavage	   ob-­‐served	   for	  5´-­‐monophosphate	   RNA	   substrates	   [117]	   have	   been	  attributed	   to	   the	   conformational	   changes	  that	   coordinate	   5´ 	  end	  recognition	  with	  the	   accurate	  positioning	   of	   the	   scissile	   bond	   in	  the	  active	  site	  [116],	  but	  the	  structural	  details	  of	  this	  change	  have	  yet	  to	  be	  elucidated.The	   protrusion	  of	  a	   looped	  region	  of	  the	   RNA	  substrate	   from	  the	  surface	  of	  the	  enzyme	  makes	  it	  possible	  for	  RNaseE	  to	  cleave	  at	   different	  distances	  from	   the	  5´	  end.	  In	   the	   two	  structures	   that	  exhibit	   looping,	   the	   RNA	   is	   positioned	   so	   that	   cleavage	   would	  occur	  after	   the	   eighth	  nucleotide	   (Fig.	  4b,c).	  Curiously,	  RNasE	   is	  capable	   of	   cleaving	   after	   the	   ^ifth	   nucleotide	   from	   the	   5´	   end	  [118],	  suggesting	  that	  a	  more	  linear	  conformation	  of	  the	  substrate	  can	   be	   adopted.	  Examination	  of	  the	   structure	   suggests	   that	   this	  may	  be	   the	   minimum	  distance	   from	   the	   5´end	  at	  which	   cleavage	  can	   occur.	   Conversely,	   the	   looping	   facility	   also	   allows	   cleavage	  much	   further	  downstream	   in	  the	  RNA	  sequence	  [116];	   	   in	  mRNA	  targets	  with	   a	   stem-­‐loop	   inserted	   just	   downstream	   of	  the	   termi-­‐nal	   nucleotide,	   the	   position	   of	   cleavage	   would	   depend	   on	   the	  length	  of	  the	  insert.	  
7.	  	  Concluding	  remarksThe	   enormous	  amount	  of	  structural	   information	  accumulated	  over	  the	  past	  ten	  years	  or	  so	  has	  transformed	  our	  understanding	  of	  the	   protein	  recognition	  of	  RNA	  termini.	  One	   of	  the	  most	  strik-­‐ing	  aspects	  of	   the	   results	   that	   have	   arisen	   from	   this	  work	  is	   the	  tremendous	   diversity	  of	   structural	   solutions	   to	   the	   problem	   of	  speci^ic	  binding	  of	  the	  5´	  and	  3´	  ends	  of	  RNA	  molecules.	  The	  structural	  studies	  have	  already	  started	  to	  pave	  the	  way	  for	  more	   incisive	   functional	   investigations	   but	   are	   still	   some	   way	  from	   completion.	   In	  part	   this	   is	  due	   to	  the	   ^lexible	   nature	   of	  the	  binding	   proteins	   involved,	   an	   important	   facet	   of	   RNA	   terminus	  recognition	   that	  has	   emerged	   from	   the	   structural	  work,	   but	   one	  that	   presents	   technical	   dif^iculties,	   particularly	   for	   crystallo-­‐
graphic	  approaches	  to	  structure	   determination.	  As	  we	   have	   seen,	  the	  best	   strategy	  for	  overcoming	   this	  dif^iculty 	  is	   to	  compare	   mul-­‐tiple	   structures	  of	  orthologues	  of	  the	  same	   protein	   with	   different	  RNA	  ligands.	  This	  approach,	  since	  it	  invariably	  involves	  production	  of	  different	   crystal	   forms,	   also	   helps	   in	   the	   detection	   of	   artefacts	  that	   may	  arise	   from	   the	   impact	   of	   crystal	   contacts	   on	  portions	  of	  the	   ligand	  or	  binding	   pocket.	  A	  second	  problem	   is	  that	  many	  pro-­‐teins	  that	  recognise	  RNA	  termini	  frequently	  do	  so	  as	  part	  of	  larger	  multimeric	  complexes.	  These	   complexes,	  which	  may	  exhibit	   addi-­‐tional	   ^lexibility,	   are	   also	   more	   dif^icult	   to	   prepare	   in	   suf^icient	  quantities	  and	  at	  the	   level	  of	  purity	  needed	  for	  structural	  analysis.	  But	   the	   ^ield	   is	   already	   moving	   to	   overcome	   such	   problems,	   on	  NMR	   and	   crystallographic	   fronts	   [57,	   89],	   and	   the	   next	   decade	  surely	  promises	  further	  fascinating	  revelations.	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